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Abstract  
Background: Root canal treatment requires adequate removal of the infection-causing 
microorganisms within the intraradicular system. Conventional root canal treatment involves 
mechanical debridement, using hand and rotary instruments, in conjunction with antimicrobial 
solutions to decrease the bacterial load to an acquiescent level. Between appointments, medicaments 
are regularly injected into the root canal space for continued antimicrobial action and to prevent 
bacterial repopulation. However, the ideal irrigant or medicament does not exist, as many possess 
cytotoxic properties that can damage the hosts tissues, leading to an inflammatory response.  
  Metallo-drugs, particularly Auphen, impart minimal side-effects on host cells when used in 
small dosages. Auphen targets aquaporins; present in human cells, plants and bacteria; and has been 
previously trialled in anti-cancer and rheumatoid arthritis treatment. Aquaporins are channels that 
regulate the inward and outward movement of water and glycerol across the cytoplasmic membrane. 
Auphen binds to the aquaporin within the channel, inhibiting its function, leading to cellular 
instability and death. The antibacterial applications of Auphen in endodontics have yet to be assessed.  
Aim: The aim of this study was to analyse the ex vivo antibacterial efficacy of Auphen combined with 
an injectable hydrogel carrier (Poloxamer 407®) against two common bacteria associated with root 
canal infection.  
Methodology: Two species, Streptococcus gordonii and Streptococcus mutans, were sourced from 
frozen glycerol stocks provided by the Department of Oral Sciences Culture Collection (University of 
Otago, NZ). An aqueous solution of Auphen at varying concentrations was prepared and the 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determined 
using a broth microdilution assay. Auphen was incorporated into Poloxamer 407 (P407) gels at 25% 
(w/v) and the gel stability evaluated. The ex vivo release profile of Auphen from the P407 
formulations and the gel dissolution profile were obtained using inductively coupled plasma-mass 
spectroscopy (ICP-MS). The antimicrobial efficacy of Auphen in a P407 gel formulation was assessed 
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on planktonic cell cultures and on mono-species biofilms using a resazurin metabolic biofilm assay. 
MIC and MBC comparisons were made between Auphen (aqueous and gel state) formulations, 
saturated calcium hydroxide, sodium hypochlorite and sterile water.   
Results: Stable Auphen-loaded P407 gels were successfully prepared. ICP-MS analysis indicated a 
linear release of Auphen from the dissolving P407 gel over the 7-day period. Aqueous Auphen ≥ 0.5 
mM completely inhibited the growth of both species after antimicrobial exposure.  
  Auphen retained its antimicrobial activity when incorporated with P407 gel, with both species 
of Streptococcus susceptible at the same concentration (MIC 0.1 mM, MBC 0.5 mM). Both aqueous 
Auphen and Auphen-loaded gels impaired growth of biofilm at concentrations ≥ 0.05 mM.  
  The viability of mono-species biofilms after 24-hours exposure to Auphen ( ≥ 0.1 mM) in 
both aqueous and gel-form was comparable to sodium hypochlorite, completely inhibiting growth. 
Saturated calcium hydroxide slowed growth of both Streptococcus biofilms but did not completely 
inhibit growth.  
 
Conclusions: Aqueous Auphen and Auphen-loaded P407 gel at 0.5 mM resulted in antimicrobial 
activity against both planktonic cultures and mono-species biofilms of S. gordonii and S. mutans. 
Auphen ( ≥ 0.5 mM), in both aqueous and gel form, resulted in superior antimicrobial ability 
compared to saturated calcium hydroxide. Within the limitations of this study, Auphen in a polymer 
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Chapter 1: Introduction 
  Microorganisms are essential for the development of periradicular disease (Kakehashi et al. 
1965; Möller 1966). Therefore, endodontic research assumes special importance in finding methods 
and materials to predictably reduce the microbial load within the root canal system for successful 
treatment. Conventional root canal treatment is accomplished through mechanical debridement and 
chemical disinfection to remove vital or necrotic tissue and eliminating infection (Byström & 
Sundqvist 1981; Vertucci 1984). But the complex and variable anatomy of the root canal system 
allows microorganisms to survive in areas not directly accessible to conventional chemo-mechanical 
preparations. Bacteria inside the intraradicular dentinal tubules and remain shielded from 
instrumentation and irrigation. The use of intracanal medicaments has been shown to provide a 
sustained antimicrobial release that may facilitate further disinfection and avoid bacterial re-
population in between appointments (Byström et al. 1985; Shuping et al. 2000; Sjögren et al. 1991).  
  Post-treatment persistent periapical disease can occur despite thorough chemo-mechanical 
debridement and placement of an antimicrobial medicament (Nair 2004). Streptococcus species have 
shown resistance to conventional root canal treatment and have frequently been isolated in failed 
extracted root treated teeth (Möller 1966). Modern endodontic research has placed importance on 
identifying a biologically safe intracanal medicament with superior antimicrobial abilities compared 
to calcium hydroxide. Preliminary non-dental research using the metallo-drug, Auphen, has shown 
promising microbicidal activity against planktonic bacteria and biofilms, but its potential within 
endodontic research has not been challenged to date.  
  Antimicrobial agents, such as Auphen, could potentially be combined with a polymer gel-
forming system to prolong the residence time of drugs and improve bioavailability (Gilbert et al. 
1986). The thermo-responsive class of hydrogels provides the advantage of convenient administration 
through phase transition upon temperature change. The use of a thermo-responsive gel may be 
beneficial for delivery of an antimicrobial agent into the root canal system for use as an intracanal 
medicament, allowing a sustained release between dental appointments. The aim of this research is to 
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evaluate the in vitro antimicrobial efficacy of Auphen in a thermo-responsive gel matrix against 
Streptococcus species commonly found in primary endodontic infections.  
  The next chapter will comprise a review of the literature including an overview of root canal 
microbiology, current antimicrobial root canal techniques, endodontic intracanal medications, 
metallo-drugs, hydrogels as carriers, and in-vitro experiments conducted to assess the stability and 






















Chapter 2: Literature Review 
2.1 Microbial basis for endodontic disease 
   The oral environment contains a diverse range of microorganisms that is largely considered 
harmless and tolerated by our immune system. Certain species are opportunistic under certain 
conditions resulting in various diseases of pulpal and periradicular origin. Disease progression 
depends on the virulence of the microorganisms, its population, and the resistance of the host. It is 
imperative to have a thorough knowledge of endodontic microbiology in order to control the disease 
process.  
  The role of bacteria in pathogenesis of endodontic infections has been extensively studied. 
Bacteria have been shown to be essential for the progression of apical periodontitis (Fabricius et al. 
1982a; Möller et al. 1981; Ricucci & Siqueira Jr 2010). The classic study by Kakehashi et al. (1965) 
observed the development of pulpal and periapical disease in surgically exposed pulpal tissues of 
germ-free (gnotobiotic) and conventional rats (normal oral microbiota). Pulpal necrosis with 
associated inflammation of the periapical tissues and abscess formation was noted only within the 
conventional rats. The gnotobiotic rats exhibited no signs of pulpal devitalization or abscess 
formation. Rather, healing was observed with the formation of a reparative dentine bridge over the 
vital pulp tissue. But a direct bacterial causative link to apical periodontitis could not be confirmed 
due to the possibility of endogenous or iatrogenic pulpal pathosis.  
  The study by Sundqvist (1976)  radiographically examined traumatized non-carious teeth. 
Two groups were assessed, teeth with and without a periapical radiolucency. The intact pulp 
chambers were accessed with microbiological sampling conducted using aerobic and anaerobic 
culturing techniques. The traumatized teeth with a periapical radiolucency were culture positive to 
bacteria. Samples without a periapical radiolucency were culture negative. The results indicated that 
microbial colonisation within the root canal system is required prior to the development of apical 
periodontitis. Further studies have confirmed these observations (Fabricius et al. 1982a; Fabricius et 
al. 1982b; Möller et al. 1981), providing the scientific basis for root canal treatment.  
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  The antibacterial principles of endodontic treatment are derived from microbiological studies 
investigating the bacterial composition and diversity of the infected intraradicular system (Byström & 
Sundqvist 1981; Dalton et al. 1998; Sjögren et al. 1991). Sampling of the microbiota within the root 
canal can be collected via paper point sampling, dentine shavings, crushed tooth samples or molecular 
microbiology (qPCR). Combined with strict anaerobic culturing techniques, such as the anaerobic 
glove box (Aranki et al. 1969; Kantz & Henry 1974; Möller 1966), researchers have isolated over 700 
indigenous species isolated within a pulpal infection.  
  Bacterial by-products, such as endotoxins like lipopolysachharides (LPS) extracted from 
gram-negative strains, were also shown to cause inflammatory reactions when placed under the skin 
(Dahlén & Hofstad 1977). Culturing techniques of the root canal microbiota have observed gram-
negative bacteria such as black-pigmented Bacteroides or Fusobacterium undergoing lysis and 
releasing endotoxins from the cell wall (Dahlén & Bergenholtz 1980). The endotoxins have been 
shown to play a role in the induction and development of periapical disease with the degree of 
inflammation dependant on the particular strain and number of bacteria (Dwyer & Torabinejad 1981; 
Pitts et al. 1982). The infected pulps, under duress, induce an inflammatory reaction in the periapical 
tissues that appears to be a prerequisite for the development of apical periodontitis (Möller et al. 
1981). 
2.1.1 Primary root canal infections 
  Prior to anaerobic incubation techniques, infected root culture studies identified 
predominantly gram-positive aerobic bacteria, with anaerobic species such as Staphylococcus and 
Bacteroides less frequently isolated (Leavitt et al. 1958). Anaerobic culturing techniques and 
molecular analysis has observed that primary intraradicular infections regularly comprise of five 
different strains and up to twenty phenotypes, with many anaerobic microorganisms (Sundqvist 1992; 
Wittgow & Sabiston 1975). In particular, facultative anaerobic bacteria have been regularly 
demonstrated in infected pulps (Baumgartner & Falkler 1991), establishing polymicrobial infections 
(Sundqvist 1992). The limitation of some molecular based methods, such as qPCR, is that same 
bacteria can be live and dead at the time of processing, therefore there may be difficulty in 
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determining the antimicrobial efficacy of treatment. 
  Bacteria commonly found in dental plaque, such as facultative or microaerophilic 
Streptococcus species, play a role in the initiation of pulpal infection by egressing through the 
dentinal tubules (Nyvad & Kilian 1987). As the available oxygen and nutrition diminishes within the 
confined root canal system, the aerobic microorganism population declines, altering the root canal 
microflora. The depletion of oxygen and lack of blood circulation associated with pulpal necrosis 
therefore favours the growth of a more fastidious anaerobic microorganisms.  
   As the nutrient supply within a necrotic root canal system becomes exhausted, 
microorganisms must obtain substrate from other sources. Residual necrotic pulpal tissue and 
endogenous proteins and glycoproteins derived from the influx of exudate from periradicular tissues 
can sustain certain species for a prolonged period. Other microbes have been shown within a biofilm 
to supply essential nutrients for the growth of other species through controlled apoptosis (Marsh 2005; 
Sundqvist 1992). Specific microbes have also been observed undergoing selective pressure, allowing 
certain species to thrive in a symbiotic relationship while others cannot survive due to antagonistic 
interactions (Love 2010). Harsh environments breed virulent microorganisms, and the primary 
colonising aerobic microorganisms eventually become replaced by obligate anaerobic species such as 
Bacteroides, Fusobacterium, Porphyromonas, Peptostreptococcus, Prevotella, Veillonella and 
Streptococcus (Byström & Sundqvist 1983; Fabricius et al. 1982a; Fabricius et al. 1982b; Möller et 
al. 1981; Sundqvist 1976).  
  Commensal organisms such as fungi have also been identified in infected root culture studies 
(Baumgartner et al. 2000; MacDonald et al. 1957; Sen et al. 1995). Fungi such as Candida spp. have 
been shown to become pathogenic under certain environments, with the most commonly isolated 
species being Candida albicans (Baumgartner et al. 2000; Siqueira & Rôças 2003). Several studies 
have shown the presence of certain fungal species in root-filled teeth with chronic apical periodontitis 
(Peciuliene et al. 2001; Waltimo et al. 1999).   
2.1.2 Post-treatment root canal infections 
   Persistent intraradicular infection is the most common cause of post-treatment disease. 
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Virulent microorganisms may survive in the apical ramifications of filled root systems and dentinal 
tubules (Nair et al. 1990; Siqueira 2001). Poorly filled canals appear to show a similar species count 
to the microbiota found in a primary intraradicular infections (Pinheiro et al. 2003). However, culture 
studies have observed that the number of species found in adequately root treated canals is very low, 1 
- 2 species on average, but with vastly different microorganisms compared to primary root canal 
microbiota (Molander et al. 1998; Sundqvist 1976).  
  Significant reductions in primary root canal microbial population is currently achieved 
through effective chemo-mechanical preparation (Byström & Sundqvist 1981; Byström & Sundqvist 
1983; Sjögren et al. 1997). Post-treatment infections are primarily composed of gram-positive species, 
particularly facultative anaerobes and to a lesser extent by obligate anaerobes. Facultative anaerobes 
can withstand antimicrobial agents better and therefore persist root canal treatment. The most 
common genera isolated are Streptococcus, Enterococcus, Peptostreptococcus, Lactobacillus, 
Actinomyces, and the most common fungi, Candida albicans (Molander et al. 1998; Rôças & Siqueira 
2012; Sundqvist et al. 1998).  
   A variety of Streptococcus species, such as S. mutans and S. gordonii, have been isolated by 
employing rigorous sampling techniques within primary infected teeth with necrotic pulps (Möller et 
al. 1981; Sundqvist 1976), after instrumentation and application of intracanal medicament (Byström 
& Sundqvist 1981), and in retreatment cases (Molander et al. 1998; Möller 1966; Sundqvist et al. 
1998). The predominance of streptococci especially in cultures taken during and after endodontic 
treatment, suggests resilience and ability to survive under sparse nutritional conditions. However, the 
mechanisms for their adaptation and role in post-treatment apical periodontitis are not entirely clear. 
  A distinguishing characteristic of multiple oral Streptococcus species is the innate ability to 
attach to the tooth surface by expressing specific proteins known as ‘adhesins’ (Jenkinson & Lamont 
1997). This adhesive mechanism allows streptococci to initiate colonisation and formation of biofilms 
in dental plaque (Whiley & Beighton 1998). Within the infected root canal space, surface attachment 
efficiency is a significant bacterial attribute contributing to the pathogenesis of apical periodontitis. 
Streptococci have been shown to invade dentinal tubules (Love & Jenkinson 2002), attaching to the 
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inner dentinal walls of infected root canals (Nair 1987). In this respect, the participation of 
streptococci may be influential to biofilm adhesion, initiation and development (Love et al. 2000).  
  Clustering of organisms has been shown to increase their ability to adapt to environmental 
changes provoked by endodontic treatment, such as the limited amount of nutrients and exposure to 
intracanal medicaments (Bowden & Hamilton 1998; Love 2001; Love & Jenkinson 2002). Hence, by 
releasing different extracellular proteins, streptococci are able to adapt and survive in these adverse 
conditions (Lindquist & Craig 1988; Watson 1990). For example, to offset detrimental acidic 
environments in dental plaque, streptococcal species are able to produce many extracellular proteins 
(Wilkins et al. 2003). The ability of Streptococcus to initiate intrinsic regulations provoked by 
environmental changes may explain its ability to survive in root canal undergoing treatment. 
Streptococcus mutans and Streptococcus gordonii were tested in the current study against the 
antimicrobial agent, Auphen.  
2.1.3 Biofilms 
   It has been observed that the endodontic microbiota in primary and secondary infections 
resembles a biofilm (Nair et al. 1990; Ricucci & Siqueira Jr 2010; Siqueira et al. 2002). A biofilm is a 
sessile and diverse community of microorganisms embedded in an extracellular polysaccharide matrix 
that is attached to a surface (Costerton 1999). Diverse microcolonies develop from adhered primary 
colonisers, strengthening the bonding surface. The multitude of proliferating bacteria forming 
microcolonies continue to support the growth of macrocolonies and the overall biofilm. This complex 
process is coordinated through metabolic communication pathways allowing genetic transfer and 
symbiotic nutritional support, along with competitive interactions to shape the complex biofilm 
community. The supported bacterial network continues to increase through efficient utilisation of 
nutrients while reducing the susceptibility to host defenses and therapeutic measures (Love 2010).  
  The development of the biofilm is a dynamic process initially requiring weak adhesion of the 
bacteria to the substrate surface. Planktonic cells initially attach by weak Van der Waals forces 
between the bacteria and the host surface followed by receptor-mediated interactions between the host 
and microbial cell surface adhesins. Initial binding occurs between planktonic cells and a complex 
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proteinaceous pellicle, which acts as an adhesive substratum for these primary bacterial colonisers 
(Love 2010). Streptococcal species are among the early colonisers and provide additional binding 
sites for the subsequent attachment of gram-positive and -negative microorganisms (Svensäter & 
Bergenholtz 2004). 
  Continued aggregation results in microcolonies with communication channels to help 
distribute plasmids, nutrients, gases and quorum sensing molecules called autoinducers (Dufour et al. 
2010; Love 2010). Quorum sensing regulates the metabolic functions, population density and biofilm 
formation and spread, affecting bacterial phenotype expression from an individual cellular level to the 
entire biofilm.  The transfer of genetic information may occur between bacteria via conjugation and 
increase the virulence of individual bacteria and the community as a whole (Kolenbrander et al. 
2010). 
Figure 2.1.3: Scanning electron microscope images of 4-week old E. faecalis biofilm grown within the lumen of 
the root canal (SEM images taken by D. Chellappa) 
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  Bacteria in a mature biofilm have several advantages over their planktonic state. 
Microorganisms within a biofilm are more resistant to antibacterial agents and have greater 
pathogenic potential than in planktonic form (Huang et al. 2011). The extracellular matrix in a biofilm 
is a physical barrier that offers protection against antimicrobial agents. Antibiotics have limited 
diffusion into the deeper portions of the polysaccharide matrix, thereby killing only the surface 
bacteria and allowing the inner regions of the biofilm to stay protected, allowing re-establishment of 
the biofilm. The lack of nutrients results in a phase transition from active to quiescent, slowing 
bacterial growth and increasing resistance to antimicrobials (Gilbert et al. 1997). Therefore, 
endodontic treatment must consider the reduced potential of antimicrobial agents on the microbiota of 
the biofilm.  
2.1.4 Invasion of dentinal tubules  
  Dentine exposed to the oral cavity due to a breach in the dentino-enamel junction (DEJ) may 
allow bacteria and their byproducts to diffuse through coronal dentinal tubules towards the pulp (Love 
& Jenkinson 2002). Invasion of bacteria will evoke an inflammatory reaction from the pulp-dentine 
immune complex, eventually becoming overwhelming, leading to pulpal and periapical disease, if left 
untreated. Invasion through coronal dentine may occur in the presence of carious lesions, restorative 
or periodontal procedures, attritional wear, microcracks or trauma. The presence of cementum on the 
external root surface acts as a barrier for bacterial penetration into the radicular tubules (Haapasalo & 
Ørstavik 1987). However, the loss of cementum may expose dentinal tubules and allow for 
microorganisms to easily egress. Once within the intraradicular space, microorganisms can penetrate 
through the radicular dentinal tubules to varying depths depending on the tubule and virulence of the 
bacteria (Chong 1995).  
  The diameter of the tubule ranges from 0.5 μm at the periphery to 3.0 μm at the pulpal surface 
(Love & Jenkinson 2002). The depth of penetration of microbes is approximately 50 to 600 μm within 
dentinal tubules, with higher populations invading in the cervical third compared to the apical 
(Haapasalo & Ørstavik 1987; Love & Jenkinson 2002). Removal of the smear layer may expose 
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dentinal tubules and allow for easier diffusion of microbes. Bacteria that invade into radicular dentinal 
tubules pose further problems to root canal treatment as they may be protected from chemo-
mechanical preparation leading to recalcitrant intracanal infection (Akpata & Blechman 1982; 
Haapasalo & Ørstavik 1987). It is imperative that the effective use of antimicrobial irrigants and 
medicaments is achieved to eliminate bacteria within the canal system. 
 2.2 Root canal treatment 
  The aim of root canal treatment is to remove the pathogenic source of disease and prevent 
reestablishment of the disease. Root canal treatment involves chemo-mechanical preparation of the 
intraradicular space using an antimicrobial and tissue dissolving agent. Intraradicular medicaments are 
used if multiple appointments are required, followed by obturation of the root canal space and 
restoration of the coronal portion of the tooth to prevent reinfection.  
2.2.1 Mechanical instrumentation   
  Mechanical instrumentation involves shaping and cleaning the root canal space (Schilder 
1974). The study by Byström & Sundqvist (1981) showed a 100 to 1000-fold decrease in microbial 
numbers when instrumentation was conducted with saline irrigation after a single visit, however 
bacteria still remained in the instrumented canals. Five separate visits were required with copious use 
of antibacterial irrigation, such as sodium hypochlorite, before elimination of bacteria was predictably 
achieved (Byström & Sundqvist 1983).  
  Mechanical preparation of the radicular space to a larger apical size has been shown to reduce 
the microbial load by disrupting the bacterial biofilm and the mechanic removal of large portions of 
the infected dentine wall. The study by Ørstavik et al. (1991) sampled bacteria from single-rooted 
teeth with apical periodontitis, that were mechanically debrided to varying sizes and irrigated with 
saline. The results showed that canals prepared to a size 35 - 40 ISO had higher number of bacteria 
containing canals compared to larger prepared canals (45 - 80 ISO). Dalton et al. (1998) confirmed 
this, and observed the initial rapid rate of bacterial reduction was achieved by the first few files 
removing the most infected layers of dentine, but the subsequent increase in apical size had a reduced 
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effect on the removal of pathogens. Therefore, increasing the size of the apical preparation does not 
lead to a linear reduction in bacterial numbers. A balance must exist between bacterial removal and 
retaining dentine structure for strength of the tooth. 
   Investigations into the ideal preparation size in the apical region for effective irrigation is not 
definitive. Some researchers have advocated sizes as small as 20-25 ISO at the apical termination, 
with copious irrigation (Buchanan 2000). Others advocate a larger apical preparation size in order to 
allow adequate access to disperse the irrigant effectively (Young et al. 2007). Taper size must also be 
considered in the preparation. A preparation with a larger taper allows for a greater volume of irrigant 
to be dispersed within the canal, compared to canals prepared with a narrow taper (Albrecht et al. 
2004). This may be partly due to the greater taper preparations allowing the needle to be inserted 
more apically (Abou-Rass & Piccinino 1982).  
  The currently available rotary file systems potentially simplify and reduce treatment time 
compared to traditional hand filing with stainless steel instruments. However, the literature has shown 
that similar antibacterial efficacy can be achieved with both techniques (Dalton et al. 1998; Rôças et 
al. 2013). Micro-CT imaging has shown that mechanical instruments, rotary or hand, do not contact 
and debride all surfaces of the root canal walls. Paqué et al. (2010) found 65-75% of the apical 4 mm 
were not contacted with either rotary or hand instruments during mechanical preparation of the oval 
shaped distal root canals of lower molars. These studies demonstrate the inadequacy of mechanical 
preparation alone to reduce pathogen levels necessary for periapical healing (Sjögren et al. 1997). 
Importance must be given to the use of an antimicrobial agent to improve the efficacy of disinfecting 







2.2.2 Limitations of mechanical instrumentation  
  Adequate mechanical preparation of the intraradicular space can be difficult to achieve due to 
the complex anatomical features of the root canal system. Natural tooth variations such as isthmuses, 
ramifications, deltas, accessory and lateral canals are commonly seen in the apical third of the root 
canal space (Nair 2006; Vertucci 1984). Developmental tooth conditions (i.e. dens invaginatus) can 
also pose a major obstacle to treatment. Calcification of the pulp chamber and radicular pulp space 
occurs due to the natural ageing process, or possibly as a response to low-grade bacterial infection or 
trauma. Internal or external resorption of the tooth due to trauma, infection, disease or other causes 
may also occur (Heithersay 2007). All these conditions create significant challenges to removing all 
bacteria from the root canal system and highlight the inability of mechanical instrumentation as a 
stand-alone root canal preparation method.  
  Bacteria within the infected root canal are able to penetrate the dentine tubules, with the depth 
of penetration dependent on the type of bacteria, diameter and contents of the dentine tubules 
(Harrison et al. 2010). A study by Matsuo et al. (2003) showed that bacteria invaded the dentine 
tubules of 70% of teeth diagnosed with apical periodontitis. After preparation, the frequency of 
bacteria invading the tubules reduced by only 5%, highlighting the need for other treatment methods 
to remove bacteria.  
2.3 Root canal irrigation 
  The aim of irrigation in root canal treatment is to dissolve organic matter in the canal, 
eliminate bacteria, lubricate the canal for instrumentation, flush debris from the canal system, and to 
remove the smear layer produced by mechanical instrumentation. Many different solutions have been 
used for irrigation, with the ideal properties outlined by Haapasalo et al. (2014): 
▪ low cost 
▪ flushing action 
▪ reduction in friction 
▪ killing of biofilm microbes 
▪ detachment of biofilm 
▪ does not weaken dentine 
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▪ broad antimicrobial spectrum 
▪ dissolve organic/inorganic matter 
▪ inactivate endotoxins 
▪ non-toxic to vital periodontal tissues  
▪ non-allergenic 
▪ temperature control  
 Unfortunately, there is no irrigant that conforms to all these properties, therefore, a 
combination of solutions can be utilised to achieve desirable results. The most commonly used 
irrigating solutions are NaOCl and EDTA. Other irrigants reported for use in endodontic practice 
include chlorhexidine digluconate (CHX), MTAD, QMiX, hydrogen peroxide, iodine potassium 
iodide, citric acid, equalinium acetate and saline.  
2.3.1 Sodium hypochlorite  
  During World War I, Dakin (1915) first introduced the use of 0.5 to 0.6% sodium 
hypochlorite as an antisepsis solution to irrigate open and infected wounds. Sodium hypochlorite was 
then recommended as an root canal irrigant by Coolidge (1919), and to date has remained the most 
used and important root canal irrigant in the world due to its broad-spectrum antibacterial nature and 
organic tissue dissolving properties (Senia et al. 1971). 
  The chemical action of sodium hypochlorite involves ionisation in water to form two highly 
reactive oxidizing agents, hypochlorite ions (OCl-) and hypochlorous acid (HOCl). Hypochlorous acid 
is highly antibacterial while the hypochlorite ion has a higher tissue-dissolving capacity. The 
concentration of these two agents is pH dependent. Hypochlorous acid predominates between pH 4-7 
whereas hypochlorite ions are more abundant at pH levels above 9. As a root canal irrigant, NaOCl is 
predominately between pH 10-12 depending on the manufacturer (Haapasalo et al. 2014).  
  The two reactive oxidizing agents are able to cause biosynthetic alterations in the cellular 
metabolism of the microorganisms by rapidly destroying the phospholipid cell membrane causing 
protein degradation and leading to cellular death (Estrela et al. 2002; Haapasalo et al. 2014). The 
broad spectrum antibacterial action of NaOCl is effective against Gram-negative and Gram-positive 
microflora, including spore-forming microorganisms such as Candida spp. (Byström & Sundqvist 
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1981; Waltimo et al. 1999). The ability of NaOCl to eliminate bacteria and break down organic 
tissues is dependent on time, concentration, agitation, temperature and volume of the solution.  
     The antibacterial and tissue dissolving activity of NaOCl is rapidly depleted once in contact 
with a large organic surface area. Studies have shown that agitation of the stagnant NaOCl solution 
will reduce the time required for tissue dissolution. Mechanical agitation can increase the number of 
reactive ions within the fluid that contact the organic tissue surface, therefore requiring less time for 
tissue breakdown (Stojicic et al. 2010). Although not commonly employed clinically, heating the 
NaOCl solution has also been shown to improve the bacterial efficacy and tissue dissolving properties 
of the irrigant (Stojicic et al. 2010). This concept has been suggested as a safer alternative to using 
higher concentrations of NaOCl, however further research is required.  
  Sodium hypochlorite has been investigated extensively using concentrations ranging from 
0.5% to 10% (Byström & Sundqvist 1983; Harrison & Hand 1981; Senia et al. 1971; Zehnder 2006). 
Some authors have recommended a concentration of 5.25% NaOCl (Harrison & Hand 1981), with 
others preferring a lower concentration of 0.5-3% (Baumgartner & Cuenin 1992; Spångberg et al. 
1973). The antimicrobial efficacy of varying NaOCl concentrations has been studied by Siqueira et al. 
(2000). The results showed that 1%, 2.5% and 5.25% NaOCl were not statistically different after 
chemo-mechanical preparation of extracted human single rooted teeth infected with E. faecalis. The 
copious use of NaOCl provided sufficient contact time and replenishment of reactive ions required to 
eliminate the bacteria within the canals. As previously mentioned, factors such as time, volume, 
heating and agitation were also shown to statistically improve the antibacterial efficacy within the root 
canal system. The in vivo study by Byström et al. (1983)  also displayed no statistical difference 
between 0.5% and 5% NaOCl in the treatment of anterior teeth with apical periodontitis, however it is 
unknown whether similar antibacterial results would occur in posterior teeth with curved canals.  
  Despite the numerous positive properties of NaOCl in root canal treatment, it is not an ideal 
irrigant. Increasing the concentration of NaOCl increases the toxicity of the solution, posing a greater 
risk of irritation to tissues. Extrusion of NaOCl to the periapical tissues and surrounding spaces can 
lead to extreme pain, haemolysis, skin ulceration and necrosis (Hülsmann & Hahn 2000; Spångberg et 
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al. 1973). Sodium hypochlorite is also unable to remove the inorganic smear layer created after 
instrumentation of the root canal space (Garberoglio & Becce 1994). Therefore, it is recommended 
that NaOCl solution is used in combination with EDTA to remove both the inorganic and organic 
components of the smear layer during root canal treatment (Baumgartner & Mader 1987; Niu et al. 
2002; Yamada et al. 1983).  
2.3.2 Ethylene diamine tetra-acetic acid (EDTA)  
  The smear layer consists of organic and inorganic material, and forms on the surface of the 
intraradicular dentine during instrumentation of the root canal. Removal of this layer is important as 
bacteria and their by-products can harbour within the root canal walls and dentinal tubules (Haapasalo 
et al. 2014). Ethylene diamine tetra-acetic acid or EDTA with cetrimide (EDTAC), have both been 
used in root canal therapy to remove the inorganic component of the smear layer due to the excellent 
chelating properties (Hülsmann et al. 2003). 
  The neutral or slightly alkaline EDTA solution binds to calcium ions within the inorganic 
hydroxyapatite component of the smear layer, exposing the dentinal tubules of the prepared 
intraradicular space. EDTA removes this layer in the coronal, middle and apical third of the roots 
(Garberoglio & Becce 1994). The removal of the organic tissue debris and material is important prior 
to removal of the smear layer, as EDTA cannot dissolve organic material and has only a minor 
antibacterial function by weakening the bacterial cell membrane without killing the cell (Hülsmann et 
al. 2003). Therefore, the use of NaOCl prior to rinsing with EDTA is recommended.  
  EDTA is available in 17% or 15% solutions, although studies have suggested 5% or 1% 
concentrations may be enough to remove the smear layer. Byström et al. (1985)  showed microbial 
reduction was improved when 15% EDTA was used as an adjunct to 5% NaOCl. Many studies have 
since shown that the full potential of antimicrobial irrigants, such as NaOCl, can be realised after the 





2.4 Root canal medication  
  Chemo-mechanical preparation removes a large percentage of microorganisms and soft tissue 
during root canal treatment; however, bacteria can survive and multiply within the complex root 
system and dentinal tubules between appointments. Previous studies have shown this survival and re-
population of microorganisms in between chemo-mechanical visits (Byström et al. 1985; Byström & 
Sundqvist 1981; Byström & Sundqvist 1983). The application of calcium hydroxide as an intracanal 
dressing is commonly used to assist in the removal of surviving bacteria, and a recommended 
treatment in clinical practice (Nerwich et al. 1993).  
  Intracanal medicaments fulfill other purposes apart from antimicrobial action. Current 
medicaments assist in reducing inflammation of periapical tissues and pulpal remnants, and 
alleviating post-operative pain (Chong & Ford 1992; Walton 1984). Dressings also have the ability to 
promote healing of calcified tissues (Heithersay 1975), and in certain cases are a form of treatment for 
inflammatory root resorption (Pierce & Lindskog 1987).   
  Like an ideal irrigant, the ideal properties of an intracanal medicament must incorporate a 
broad antimicrobial spectrum over a prolonged period. The substance should be non-toxic, stable in 
solutions, easily removed, non-staining, and able to penetrate the length of dentinal tubules. Currently, 
there is no medicament that possesses these ideal properties and consequently, endodontic research 
has shown importance in identifying agents to achieve predictability in root canal treatment. 
   Medicaments previously used include; paraformaldehyde, parachlorophenol, camphorated 
paramonochlorophenol, formocresol, cresol, creosote, thymol, eugenol, glutaraldehyde 
metacresylacetate (Cresatin), sodium hypochlorite, iodine compounds, chlorhexidine gluconate, 
chlorine compounds, quaternary ammonium compounds, Cresophene®, calcium hydroxide non-
setting paste, Ledermix® paste, Septomixine® Forte paste, Pulpomixine® paste, and Odontopaste® 
(Abbott 1990). The most common, currently used intracanal medicaments are discussed in detail in 





2.4.1 Calcium hydroxide  
  Calcium hydroxide is the most common dressing used in root canal treatment. It was initially 
introduced to endodontics by Hermann in 1920 as a treatment for vital pulp therapy. The strongly 
alkaline properties of the dressing, with a pH between 11.5 to 12.5, leads to cellular death of 
microorganisms on direct contact. The high pH environment created due to the presence of calcium 
hydroxide within the confined root canal space also leads to death of bacteria not in direct contact 
(Heithersay 1975). Calcium hydroxide is a white odourless powder with a low solubility in water. The 
powder must be mixed with a liquid, paste or gel-releasing compound for maximum effect within the 
canal. When incorporated into an aqueous solution, the compound dissociates into calcium and 
hydroxyl ions. The efficacy is highly dependent on the availability of the hydroxyl ions as they are 
responsible for damaging the phospholipid component of bacterial cell membranes. The ions react 
with bacterial DNA within the cell membrane, inhibiting replication and leading to the denaturation of 
proteins and cellular death.  
  As previously discussed, residual bacteria can egress within dentinal tubules. Hydroxyl ions 
must be able to diffuse into these tubules to sufficiently deplete the bacterial load within the root canal 
system. Nerwich et al. (1993) studied the tubular penetration of calcium hydroxide by measuring pH 
changes at different depths within the radicular dentine. The medicament was shown to diffuse into 
the inner radicular dentinal tubules within a few hours but required seven days to reach the outer 
tubules. Ørstavik and Haapasalo (1990) showed that it can take up to ten days for disinfection of 
dentinal tubules with calcium hydroxide due to the decreasing tubular diameter towards the external 
root surface. Dentine also has the ability to buffer the hydroxyl ions diffusing within tubules due to 
the presence of hydroxyapatite (Wang & Hume 1988).  
  Calcium hydroxide is an effective antimicrobial agent, and has been shown to be superior to 
camphorated paramonochlorophenol and camphorated phenol (Byström et al. 1985). However, 
studies have shown that calcium hydroxide is ineffective at predictably eliminating certain 
Streptococcus and Enterococcus species (Baker et al. 2004; Evans et al. 2002; Ørstavik & Haapasalo 
1990; Safavi et al. 1990). Waltimo et al. (1999) also showed that Candida spp. was resistant to 
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calcium hydroxide, highlighting that there is no current medicament that is effective against the broad 
microbiota within the root canal system.  
 2.4.2 Ledermix® paste  
  Ledermix® paste consists of 1% triamcinolone acetonide (corticosteroid) and 3% 
demeclocycline (antibiotic). The corticosteroid component acts as an anti-inflammatory agent, 
providing relief from pain in symptomatic cases (Ehrmann 1965; Ehrmann et al. 2007) and 
inflammatory root resorption defects (Pierce & Lindskog 1987). The antibiotic component also acts as 
a potent antibacterial agent (Taylor et al. 1989).  
  The use of Ledermix® has declined due to the tooth discolouration associated with its 
prolonged use. Studies have shown that the tetracycline component is responsible for staining of the 
hard tissues. The demeclocycline has also been shown to act as a bacteriostatic agent rather than a 
bactericidal agent, limiting its potential (Kim et al. 2000). The study by Abbott et al. (1988) on the 
diffusion of corticosteroid and tetracycline tracer molecules through dentine reported a peak in 
concentration of demeclocycline through the radicular dentinal 
tubules within the first day after placement. This declined 
exponentially over 7 days, suggesting that demeclocycline may 
only be effective against microorganisms in the first few days.  
2.4.3 Odontopaste®    
Odontopaste® is a non-staining alternative 
to Ledermix® (Chen et al. 2012). The zinc oxide-
based paste contains 1% triamcinolone acetonide as 
the corticosteroid and 5% clindamycin 
hydrochloride as the antibiotic. The medicament has 
similar functions to Ledermix® in that it is 
bacteriostatic, reduces inflammation and post-operative pain. The antibiotic component has been 
shown to be as effective to many endodontic microorganisms, however the effectiveness compared to 
Figure 2.4.2: Ledermix® paste 
Figure 2.4.3: Odontopaste® medicament 
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calcium hydroxide in inhibiting bacterial growth is still unclear, with further research required 
(Molander et al. 1990). 
2.5. Metallo-drugs 
  Key discoveries in the last century have enabled a new era of research into inorganic 
compounds for medicinal applications. The archetypal metal-based anti-cancer agent, cisplatin ([cis-
[PTCl2(NH3)] or Platinol®), was approved by the Food and Drug Administration (USA) in 1978 and 
is still widely used worldwide against many types of malignancies, alone and in combination therapy 
(Jayson et al. 2014; Kelland 2007). Since the discovery of cisplatin, research has focused on improved 
anti-cancer metallo-drugs with fewer side-effects and different mechanisms of action using dissimilar 
transition metals, including gold compounds.  
  Of all elements, gold has always fascinated mankind, leaving a mark on culture arts and of 
course medicine. The earliest therapeutic use of gold can be traced back to the ancient Egyptian and 
Chinese cultures around 3000 – 25000 BCE.  In the Medieval age, alchemists developed numerous 
methods for preparing elixirs containing colloidal gold. Later in the 17th century, a concoction could 
be readily found in pharmacopeias, containing a suspension of the finely-divided noble metal to treat 
fevers, melancholy, fainting and sickness (Fricker 1996; Higby 1982).   
  In modern medicine, the use of gold-based compounds, also known as chrysotherapy, was 
pioneered by the German Nobel laureate Robert Koch, who discovered in 1890 the bacteriostatic 
activity of gold (I) compounds against tubercle bacilli. Unfortunately, its use against tuberculosis was 
proven to be ineffective (Fricker 1996), but clinical studies have shown the effectiveness of 
chrysotherapy against the autoimmune disease rheumatoid arthritis (Higby 1982). In the 1980s, gold 
(III) compounds appeared in anti-cancer research as a logical step forward from platinum (II)-based 
compounds. But in comparison with platinum (II) compounds, gold (III) analogues turned out to be 
relatively unstable, light-sensitive and easily reduced to metallic gold under physiological conditions. 
As a consequence, these difficulties heavily hindered their pharmaceutical applications and gold (III) 
compounds were rapidly abandoned and neglected for several years (Higby 1982). 
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2.5.1 [Au(phen)Cl2]Cl or Auphen 
  Over the last two decades, there has been a re-emergence of several gold (III) and organogold 
(III) compounds characterised by a great structural variety and encouraging pharmacological 
properties such as; [Au(en2)]Cl3, [Au(cyclam)](ClO4)2Cl and [Au(phen)Cl2]Cl, where phen is 1,10- 
phenanthroline. Solutions were investigated through various physico-chemical methods using visible 
absorption spectroscopy, ESI mass spectrometry and chloride-selective potentiometric measurements 
with encouraging results (Messori et al. 2000).  
  In particular, the gold (III) compound, [Au(phen)Cl2]Cl or Auphen, has the most potent 
properties related to the inhibition of different protein targets, particularly aquaporins, and anti-
proliferative effects of human cancer cells in-vitro (Casini et al. 2009; Messori et al. 2000). Gold 
complexes were shown to act as protein-binders to sulfur nucleophilic sites such as the thiol side-
chain of cysteine residues (de Almeida et al. 2014). Currently, there has been no research conducted 










Figure 2.5.1: (Left) Schematic drawing of the metal compound, Auphen, used in the present study. 
(Right) Photograph of Auphen powder. 
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2.5.2 Aquaporins  
  Water is the most abundant and basic molecule within every cell. The plasma membrane, 
comprising of a phospholipid bilayer, serves to protect the intracellular biome and its components 
from the external environment by maintaining an optimal internal cellular environment (i.e. pH, ionic 
strength, concentration of inorganic ions). Water and small polar molecules can diffuse through the 
phospholipid bilayer to maintain the internal environment. Specialised integral membrane protein 
channels facilitate the efficient permeation of water, glycerol, urea and ions across the membrane. 
Such water and ion channel proteins have been found in organisms ranging from bacteria to plants 
and animals (Chrispeels & Maurel 1994), and were coined aquaporins (AQPs) by Agre et al. (1993b).  
Figure 2.5.2a: Structure of an aquaporin within a cell membrane. 
  The serendipitous discovery of a red-blood-cell protein led to the description of aquaporin-1 
(AQP1) as the first molecular water channel in 1986 (Benga et al. 1986b; Benga et al. 1986a). AQPs 
are water channel proteins that belong to the major intrinsic protein (MIP) family (King et al. 2004). 
AQPs comprise of a family of small hydrophobic integral transmembrane water channel proteins 
involved in transcellular and transepithelial water movement (Soveral et al. 2018).  
  AQPs can be characterised into three major sub-groups determined by their transport 
capabilities; orthodox, aquaglyceroporins and S-aquaporins. Orthodox aquaporins are water-specific 
channels only. Aquaglyceroporins also allow non-polar solutes, such as glycerol, polyols, urea, 
hydrogen peroxide, ammonia, metalloids and gases to diffuse through the membrane (Hill et al. 2004; 
Takata et al. 2004). S-aquaporins, also known as super-aquaporins or subcellular-aquaporins, are 
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unclassifiable by the first two groups (Ishibashi 2006). In mammals, thirteen different aquaporin 
isoforms (AQP0-12) have been identified in different tissues and involve many biological functions, 
as shown in Table 2.5.2c (Graziani et al. 2017).  
  Compared with ion channels and solute transporters, AQPs are relatively simple proteins. 
Early low-resolution AQP structures were observed by electron crystallography, composed of a 
bundle of six transmembrane α-helices embedded in the cell membrane. A greater insight into the 
atomic-level mechanisms of water and solute conduction was then observed using high-resolution X-
ray crystal structures and provided the basis for virtual screening and molecular dynamics simulations 
(Verkman et al. 2014).  
   AQPs are between 150-290 amino acids in length and comprise a NH2 and COOH terminus 
which are hydrophilic and located in the cytosol and two short helical segments (HB and HE) that 
surround cytoplasmic and extracellular vestibules, respectively. Four AQP monomers assemble to 
form tetramers in the plasma membrane. The monomers are connected by a narrow aqueous pore of   ̴ 
25 Å (1 Å= 0.1 nm) in length (Graziani et al. 2017; Verkman 2011; Verkman et al. 2014). The 
tetramers create a distinctive hourglass shape, with a narrow water channel centrally and wider at each 
end. The pore provides a pathway for water permeation across biological membranes, and the target 
for metallo-drugs to bind and occlude its fundamental function (Figure 2.5.2b). The channel pore is 
formed by two highly conserved regions in the amino acid sequence, called NPA boxes (or motifs) 
with three amino acid residues (asparagine–proline–alanine) and several surrounding amino acids in 
the centre of the AQP fold. The NPA motifs are deemed the signature sequence of AQPs, however 
research has shown considerable variation (El Karkouri et al. 2005; Gonen & Walz 2006; Zardoya 
2005). Another pore component is the ar/R selectivity filter, which is a narrow portion of the pore, 
comprising of a cluster of amino acids enabling the aquaporin to selectively let through or block the 
passage of different molecules. The filter binds to water molecules and move the molecule along the 




Figure 2.5.2b: Structure of AQPs. (A) A top view of the extracellular face of an AQP1 homo-tetramer, 
with monomers labelled 1–4. (B) A schematic of AQP membrane topography. (C) Structure of the 
AQP1 monomeric unit, which shows key helical domains (labelled M1–M8) and connecting linkers 
(labelled a–e). (D) A view into the extracellular vestibule of AQP1. The constriction region (in green) 
is made up of aromatic and arginine residues; extracellular Asn-Pro-Ala (NPA) residues are shown 
in orange; backbone α-carbonyl hydrogen-bond acceptors (Ile192, Cys191, Gly190 and Gly189) are 
shown in violet; and hydrophobic side chains comprising non-polar amphipathic surface are shown in 
black. (Verkman et al. 2014) 
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AQP Permeability Tissue distribution Sub-cellular distribution 
AQP0 Water  Lens Plasma membrane 
AQP1 Water Red blood cell, kidney, lung, vascular 
endothelium, brain, eye, ear 
Plasma membrane 
 
AQP2 Water Kidney, vas deferens Apical plasma membrane, 
intracellular vesicles 
AQP3 Water, glycerol (high), urea 
(moderate) 
Kidney, skin, lung, eye, colon, urinary 
and digestive tracts 
Basolateral plasma membrane 
AQP4 Water Brain, muscle, kidney, lung, stomach, 
small intestine, sweat glands 
Basolateral plasma membrane 
AQP5 Water Salivary gland, lacrimal gland, sweat 
gland, lung, cornea, ear 
Apical plasma membrane 
 
AQP6 Water, anions  Kidney Intracellular vesicles 
AQP7 Water, glycerol (high), urea 
(high), arsenite 
Adipose tissue, kidney, testis Plasma membrane 
 




AQP9 Water, glycerol (high), urea 
(high), arsenite 
 
Liver, leukocytes, brain, testis Plasma membrane 
AQP10 Water, glycerol (high), urea Small intestine Intracellular vesicles 
AQP11 Water Brain, duodenum, Small intestine Intracellular vesicles 
AQP12 Water Pancreas Intracellular vesicles  
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2.5.3 AQPs in Microorganisms  
  AQPs are abundant in mammals and plants, assisting in regulating water homeostasis. 
Genome sequencing programs have revealed that only some microorganisms encode AQPs (Hohmann 
et al. 2000; Kayingo et al. 2001). Water channel proteins have been shown to be more abundant in 
eukaryotes (67% of 33 species) rather than in prokaryotes (26% of 193 species), and are only found in 
three of 22 sequenced Archaea and present in many lower fungi (Takata et al. 2004). In relation to the 
oral microbiota, AQPs have been found in microorganisms such as; Enterococcus, Streptococcus, 
Pseudomonas and Candida species (Tanghe et al. 2006). The absence of aquaporins in many 
microorganisms indicates that they are not essential for universal microbial survival. 
  Microbial cells with AQPs, like mammals and plants, enhance water permeability, however 
there is conjecture if this is their primary function (Tanghe et al. 2006). Osmoregulation has been 
discussed as an alternative function for microorganisms (Bonhivers et al. 1998; Carbrey et al. 2001). 
Osmoregulation assists in permitting faster influx and efflux of water under low temperatures when 
the phospholipid membrane becomes less fluid (Calamita et al. 1995; Soveral et al. 2018). The most 
remarkable feature of the AQP channels in bacteria is their high selectivity and efficiency for water or 
glycerol permeation; in fact, AQPs allow water/glycerol to move freely and bidirectionally across the 
cell membrane but exclude all ions such as hydroxide, hydronium ions and protons, the latter being 
essential to preserve the electrochemical potential across the membrane (Agre et al. 1993).  
2.5.4 Inhibition of AQPs by metallodrugs 
  Pharmacological research has extended well beyond assessment of in vitro cytotoxicity by 
analysing the action of gold compounds on several potentially relevant cellular processes such as 
direct DNA damage, modification of the cell cycle, mitochondrial effects and induction of apoptosis 
(Calamita et al. 1995; Casini et al. 2009; de Almeida et al. 2014; Marcon et al. 2003). But for as 
much as we understand about the molecular mechanisms, the observed biological effects produced 
remain largely unknown.  
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  The mechanistic studies carried out on gold (III) complexes have always been compared to 
the anti-cancer drug, cisplatin, even though the respective molecular mechanisms are rather distinct. 
In 2012, the study by Martins et al. (2012) showed the potent and selective inhibition of human AQP3 
by a series of gold (III) coordination compounds with nitrogen-donor ligands. These compounds 
could potently inhibit glycerol transport by AQP3 in human red blood cells through the orthodox 
water channel, human AQP1. The most potent inhibitor of the series, Auphen, was shown to have a 
minimal effective concentration in the low micromolar range (0.8 - 0.08 mM) and was far more 
effective than the mercurial compound HgCl2 in inhibiting AQP3 (Martins et al. 2012).  
  It has been observed that gold-containing compounds appear to have a high affinity for 
binding to sulphur-containing nucleophiles found within the tetramer of the AQPs. The inhibition of 
these glycerol channels by Auphen occurs through steric occlusion of the water and glycerol channels 
of cells and bacteria (Martins et al. 2012). Using computational modelling, gold-based inhibitors, such 
as Auphen and its analogues, may interact with the thiol groups of cysteine in AQPs, as observed in 
the extracellular domain of AQP3 (Graziani et al. 2017). In combination with molecular docking 
studies, Auphen molecules were observed positioned in close proximity to Cys40, thus rendering the 
direct binding of gold (III) to this residue (Martins et al. 2012). Other experimental evidence has also 
shown that gold (III) compounds may exert their cytotoxic effects directly on mitochondria through 
modification of specific AQPs (Messori et al. 2000).  
   Progress in the identification of agents that modulate water permeation through AQPs has 
been very challenging compared to modulation of other protein channels. The presence of artefacts 
observed in water permeation assays have made it difficult to formulate robust gold-standard assays 
of AQP activity (Verkman et al. 2014). Currently, the number of small-molecule AQP inhibitors 
appears to be very low compared to other membrane proteins. The small size of the AQP monomer 
and pore may prevent the access of small molecules, translating to poor drug potential. Also, as AQPs 
transport small, neutral molecules, electrostatic interactions are limited to those between hydrogen-
bond donors and acceptors, rather than interactions involving charges. Finally, mutations in the 
extracellular cytoplasmic domains of AQPs have little effect on the permeability of the channel, 
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suggesting that binding of an inhibitor must occur in the deep narrow AQP pore to physically prevent 
water conduction (Verkman et al. 2014).  
2.5.5 Side-effects of gold metallo-drugs  
  The occurrence of side-effects is strongly dependent on the structure, ligands and 
concentration of the respective gold agents. Gold-based compounds, such as Auphen, require the 
accumulation of the compound within the body to exhibit any side-effects. Side-effects observed have 
affected the skin (skin rashes, dermatitis, stomatitis), blood (thrombocytopenia), kidney (nephropathy) 
and other organs containing AQPs (Clark et al. 1989; Hofmann et al. 1986; Taukumova et al. 1999).  
  Toxic effects on the brain have also been researched using mice (Suwalsky et al. 2004). The 
long-term toxic effects did not readily develop and appear to only be of relevance only at extremely 
high doses. Investigation of the gold content of the brain resulted in concentrations well below the 
detection limit of the used atomic absorption spectrometer (Suwalsky et al. 2004). No other major 
side-effects have been associated with Auphen drug use as the toxic dosage far exceeds any 
prescribed amount. 
2.6 Hydrogels 
  Hydrogels have the ideal properties required of a matrix vehicle for an antimicrobial agent for 
use between root canal treatment visits. Hydrogels are stable, biocompatible with host tissues, 
biodegradable and allow the sustained release of the antimicrobial agent over an accepted period of 
time (Veyries et al. 1999). Polymer gel-forming systems were first introduced in the early 1950s in 
food additives, detergent formulations and cosmetics. The pharmaceutical industry has used hydrogels 
in defoaming/foaming agents, detergents, dispersing agents, emulsifying agents, gelling agents and 
solubilising agents due to its water-soluble, non-toxic and inert surfactant properties (Garcia Sagrado 
et al. 1994).  
  Hydrogels are crosslinked polymers that can swell into an aqueous medium by chemical or 
physical means, depending on the properties of the polymer and experimental conditions. Chemical 
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gels involve covalent crosslinking and are irreversible. Conversely, physical gels are crosslinked 
through hydrophobic association, chain aggregation, crystallisation, ion-polymer/polymer-polymer 
complexation, or hydrogen bonding (Omidian & Park 2012). The excellent water affinity, 
biocompatibility, high thermal and mechanical stability hydrogel properties are ideal for medicine, 
pharmaceuticals and dentistry (Hoffman 2012).  
  Polymer-based gels transition from solution to gel due to changes in temperature or pH. 
Thermo-responsive hydrogels such as poly(N-isopropyl acryl-amide), cellulose derivatives, and 
polyoxyethylene-polyoxypropylene-polyoxyethylene polymers, transition upon heating or cooling due 
to changes in intermolecular interactions (Chen et al. 2013). Low temperatures alters the gel to a 
soluble state, and insoluble when the temperature rises above the threshold as the hydrogen bonds are 
converted to hydrophobic interactions (Omidian & Park 2012). Polymer-based gels, such as those 
containing carboxyl or amino groups, undergo hydration and ionisation changes depending on the pH 
of the medium. The variable pH gradient within the confines of the root canal system creates 
unpredictability in the gel-transition phase and may take longer than expected to form a gel (Omidian 
& Park 2012). Ideally, the faster the gel transformation occurs, the less chance there is that the gel 
dilutes with any retained physiological fluid within the intraradicular space (Charrueau et al. 2001; 
Kojarunchitt et al. 2011). Conversely, a longer setting time may result in the undesired side effect 
known as dose dumping, releasing the drug over a shortened period. Dose dumping may also limit the 
drug release to a small fraction in a modified release dosage form (Meyer & Hussain 2005). 
Therefore, the use of a thermo-responsive gel as a drug vehicle within the root canal space is a more 
predictable and reliable method compared to pH responsive gels.  
     Figure 2.6: Structure of polymer gels. 
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  Poloxamers, or pluronics, are a class of thermo-responsive polymer gels composed of a 
central hydrophobic core of polyoxypropylene (PPO) surrounded by hydrophilic blocks of 
polyoxyethylene (PEO) to produce a triblock structure (Figure 2.6) (Dumortier et al. 2006). Pluronics 
are created by sequential anionic polymerisation of PPO and PEO monomers combined with sodium 
or potassium hydroxide (Kabanov et al. 2002; Schmolka 1972). By modifying the ratios of the 
hydrophilic and hydrophobic components, different polymers with varied molecular weights and 
altered lipophilicity and hydrophilicity properties can be developed for the desired purpose.   
  Thermo-responsive hydrogels have the unique ability to disperse the drug as an aqueous 
solution within the root canal space, that forms a semi-solid gel at physiological temperatures. Once 
Tsol-gel  (transition temperature) is reached, the viscosity increases due to the formation of aggregated 
micelles. Below this temperature, the gel reverts back to an aqueous state without alteration of their 
properties (Schmolka 1972). Poloxamer 407 (P407) (Merck®, Darmastadt, Germany) is a thermo-
reversible gel that has been extensively studied and shown to form strong gels that are efficient in the 
slow release of active drugs (Bhardwaj & Blanchard 1996). In this current research, P407 is expected 
to transform into a gel shortly after administration within the root canal in response to body 
temperature and slowly dissolve over a week, releasing Auphen.  
2.6.1 Poloxamer 407 
  P407 or Pluronic® F127 (BASF Laboratories, Wyandotte, USA) gels are non-toxic colourless 
gels with an approximate molecular weight of 12,600 as determined by mass spectrometry (Takáts et 
al. 2001). The gel consists of 70% PEO and 30% PPO in a ratio of approximately 2:1 (Schmolka 
1972). Depending on the concentration, temperatures lower than 20oC form an aqueous P407 solution. 
P407 forms a semi-solid when the temperature reaches above approximately 25oC, and at 
physiological temperatures (37oC), P407 forms a gel (Johnston & Miller 1985).  
  P407 is an amphiphilic block polymer producing a spherical structure in the presence of 
water. The spherical structure observed is due to the formation of micelles as the PPO hydrophobic 
core dehydrates (Chen-Chow & Frank 1981; Juhasz et al. 1989). Micellae are an aggregate of 
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surfactant molecules dispersed in a liquid colloid and are characterised by a dehydrated core with an 
outer structure of swollen chains (Cabana et al. 1997; Moore et al. 2000). At high temperatures, 
micelles combine due to hydrophobic interactions between the dehydrated PPO blocks resulting in gel 
formation (Figure 2.6.1). P407 is limited within aqueous environments, as the copolymers become 
diluted as the excess solvent leads to a drop below the minimum gelation concentration (Chun et al. 
2005). The excess solvent leads to erosion, low mechanical strength and limited micellar stability 
(Kojarunchitt et al. 2011).   
  
    Figure 2.6.1a: Poloxamer gelation (Dumortier et al. 2006) 
  Different types of crystalline structures are formed depending on the concentration of P407. A 
face-centred cubic packing of micelles is formed at concentrations ranging from 20-40% w/v. At 
higher concentrations (50% w/v), a body-centred cubic packing of micelles is formed (Figure 2.6.1b) 
(Liu & Chu 2000). A body-centred configuration results in a more viscous, rigid and extremely slow 
dissolving gel due to the shorter inter-micellar distance, increased cross-linking and greater micelles 
per unit volume  (Bhardwaj & Blanchard 1996). 
     Figure 2.6.1b: Crystalline structures produced with the varying concentrations of P407 
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Drugs and vaccines incorporated into P407 gels have been used in transdermal, injectable and 
ocular methods due to the favourable temperature-sensitive composition (Miller & Donovan 1982; 
Miyazaki et al. 1984; Paavola et al. 1998). Active drugs and medicines can be combined with P407 in 
the aqueous state and subsequently heated to transition the combined solution to a gel. At body 
temperature, the gel can be injected and its drug released within a localised area (Bobbala & Hook 
2016). P407 is also the most commonly used gel-forming polymer matrix to deliver proteins 
(Gombotz & Pettit 1995; Juhasz et al. 1989; Morikawa et al. 1987).  
The use of Poloxamers in endodontics is minimal. Poloxamers have been tested as a dentifrice 
surfactant (Ong & Strahan 1989; Zinner et al. 1977), administered directly into the gingival pocket  
for periodontitis treatment (Esposito et al. 1996; Garala et al. 2013; Medlicott et al. 1994), and as 
thickening agents in bleaching systems (Soldani et al. 2010). Endodontic applications incorporating 
P407 as a matrix has been used for the delivery of Artocarpus lakoocha extract, a tropical tree species 
found in India and Thailand, within the root canal model (Teanpaisan et al. 2013). The study showed 
that the extract when combined with P407 had superior antimicrobial properties to calcium hydroxide 
paste against E. faecalis. Another study used P407 as a matrix for the release of antimicrobial peptides 
(BM2) successfully against common endodontic pathogens in microtitre plates (Aggarwala et al. 
2016).  
  The poloxamer gel will be used for the present study due to its superior biocompatibility, 
chemical stability, and minor immunogenic properties (Ricci et al. 2002). By incorporating Auphen 
with P407, a controlled, sustained drug delivery may be implemented into the intraradicular system. 
Studies of the rheological characteristics are needed as this will determine the rate of gel dissolution 
and rate of release of drug from the gel. Determination of the stability of P407 with and without the 
incorporation of Auphen is needed to assess whether Auphen impacts on the stability and in addition 





2.6.2 In vitro gel stability testing 
  Stability testing of the gel with and without incorporating Auphen is required to understand 
the behavioural traits of the material. As previously discussed, P407 gel dissolves in the presence of 
water as a result of ionisation, protonation, or hydrolysis of the water-insoluble side-groups (Gombotz 
& Pettit 1995). A dissolution profile can be obtained through measurement of change in polymer 
weight over time with the use of a release medium (Bobbala & Hook 2016).  
2.6.3 In vitro gel release studies  
  Rheological properties of polymer gels and their in vitro release characteristics have 
previously been studied (Chen-Chow & Frank 1981; Moore et al. 2000; Veyries et al. 1999). Release 
of the active drug is controlled by the surface hydration rate. The more lipophilic the drug, the more it 
becomes incorporated within the micelles due to more hydrophobic interactions with the PPO core, 
with less present in the aqueous channels to be released. Increasing concentrations of P407 may be 
associated with a reduced rate of release which is attributed to the higher degree of micellar 
aggregation resulting in a stronger gel. This results in greater tortuosity in the aqueous phase of the 










Figure 2.6.3: Photograph of Poloxamer 407 powder 
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2.7 In vitro antimicrobial testing  
2.7.1 Planktonic cells  
  The minimum inhibitory concentration (MIC) of an antimicrobial agent is the lowest 
concentration required to inhibit the visible growth (turbidity) of a microorganism after a defined 
incubation period (Andrews 2001). MICs are used as a diagnostic laboratory tool for assessing the in 
vitro activity of new antimicrobials against different planktonic microbes.  
  Two techniques are employed in the laboratory to determine MIC: agar and broth dilution 
methods (Wiegand et al. 2008). An antimicrobial stock solution of known concentration is prepared 
with serial 10-fold dilutions to produce a range of concentrations. The microbial suspension is grown 
as a pure culture and the optical density is adjusted to a density comparable to a McFarland turbidity 
0.5 standard (McFarland 1907). Obtaining the cell number in the final inoculum is important to obtain 
accurate results, with the recommendation of 5 x 105 colony forming units (CFU/mL) (Wiegand et al. 
2008). Broth dilution is carried out in a microtitre plate using a liquid medium. Agar dilution involves 
incorporating the antimicrobial concentrations into a nutrient agar medium, onto which the microbial 
inoculum is then placed. The MIC is determined after the predetermined incubation period. The broth 
microdilution assay, recommended by the Clinical and Laboratory Standards Insititute (CLSI) (2008), 
allows the use of smaller quantities of antimicrobial and growth medium and is the technique 
employed in this research (Griffin et al. 2000) 
  The limitation with the use of MICs is that current techniques are semi-quantitative and give 
an approximation of the lowest concentration. The values should be used as an indicator of activity 
rather than as a substantive value. The technique also does not indicate the mode of action (static or 
cidal) of the antimicrobial agent, with further studies required.  
  The minimum bactericidal concentration (MBC) is the lowest concentration at which the 
antimicrobial agent is able to prevent complete growth and kill microorganisms after incubation and 
subculturing (Andrews 2001). The MBC is established by subculturing the broth dilution showing no 
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signs of turbidity from the microtitre plate onto an appropriate nutrient agar and checking for the 
absence of growth (Mah 2014).  
2.7.2 Biofilms 
2.7.2.1 Resazurin Assay    
 Resazurin assays are simple, rapid, efficient, reliable, sensitive, safe and cost-effective 
measurements of cell viability. Used as an alternative to the time-consuming and technique sensitive 
method of plating biofilms, resazurin is used in cell viability assays for mammalian cells, bacteria and 
also been applied extensively in susceptibility testing of fungi, Mycobacterium tuberculosis, 
Staphylococcus epidermidis and Streptococcus mutans (Carrillo‐Muñoz et al. 2006; Palomino et al. 
2002; Pettit et al. 2005; Wei et al. 2006). The active ingredient of the assay is resazurin, also known 
as diazo-resorcinol or Alamar-Blue®, which is water-soluble, stable in culture medium, non-toxic and 
permeable through cell membranes.   
  First used to assess bacterial or yeast contamination in milk (Pesch & Simmert 1929), 
resazurin is a blue non-fluorescent dye that is reduced to the pink-coloured, highly fluorescent 
resorufin (Page et al. 1993). Mitochondrial reductases and other enzymes located in the cytoplasm of 
cells, bacteria and other organisms are able to reduce resazurin, and as the indicator dye accepts 
electrons, it changes from the oxidized, non-fluorescent, blue state to the reduced, fluorescent, pink 
state (Page et al. 1993). This change from oxidized to reduced state allows flexibility of detection 
where measurements can be quantitative colourimetry, or fluorometric readings, or qualitative as a 
visible change in colour indicating presence or absence of viable cells. Greater sensitivity is achieved 
when the fluorescent signals are measured at an excitation wavelength at 530–560 nm and an 
emission wavelength at 570-610 nm (Rampersad 2012). 
  The assay is used in 1- 10% concentrations, with care taken as resazurin is pH, light and 
temperature sensitive. It is recommended that the assay is at an optimum pH of 7.0 - 7.4, with the 
microtitre plates (Greiner Bio-One GmbH) incubated at 37oC, sealed and stored in a dark environment 
(Palomino et al. 2002). Assays must be carried out at a uniform temperature to ensure reproducibility 
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of all wells and across a single plate. Negative and positive controls are required to ensure that there 
are no non-specific interactions with the assay that may result in false-positive signals (Pettit et al. 
2005).  
  The fluorescence measurements have been shown to have a direct correlation between the 
reduction of resazurin in the growth media and the quantity of bacteria, comparing well with other cell 
proliferation techniques (Page et al. 1993; Palomino et al. 2002; Pettit et al. 2005). Inaccuracies can 
occur when extensive reduction of resorufin (pink) to the non-fluorescent hydro-resorufin (colourless) 
occurs. The reduction from the fluorescent to non-fluorescent product may lead to aberrant results as 
the signal produced is weak when the opposite is true, as the assay could not sustain further reduction 
(Palomino et al. 2002; Pettit et al. 2005). To avoid this error, it is recommended to measure the 
fluorescence over multiple points over 24 hours and recording the highest result. The resazurin assay 
was used in this study to examine the biofilm viability after the antimicrobial period on S. mutans and 















2.8 Aims  
  Preliminary in vitro studies indicated the metallo-drug, Auphen, to be an effective 
antimicrobial agent against Enterococcus faecalis and mono-species biofilms when tested in solution. 
The antimicrobial efficacy of Auphen prepared as an injectable gel matrix requires investigation.  
 
The aims of this research are:  
1) To develop a stable sustained-release delivery system suitable for the intracanal delivery of Auphen  
2) To evaluate the in vitro release of Auphen from P407 gel.  
3) To assess the susceptibility of Streptococcus species to Auphen in a gel medium.  
4) To assess the antimicrobial effect of Auphen in a gel medium on mono-species Streptococcus 
biofilms by comparison with the currently used intraradicular medicament, calcium hydroxide.  
2.9 Hypotheses  
The following hypotheses were tested:  
1) Auphen incorporated into a P407 matrix is stable and suitable as an intracanal delivery system.  
2) Auphen is released over a clinically effective period from P407 gels.  
3) Planktonic cultures of bacteria are susceptible to Auphen-loaded P407 gels. 
4) Auphen-loaded P407 gels demonstrate antimicrobial activity against mono-species biofilms.  







Chapter 3: Materials and Methods 
3.1 Selection of Microbes  
  The two microorganisms used in this study were sourced from the Department of Oral 
Sciences Culture Collection (University of Otago, NZ). Strains available under PC1 laboratory 
conditions and representing species frequently isolated from an infected root canal system were 
chosen, namely Streptococcus mutans UAB159 and Streptococcus gordonii DL1. Strains were 
obtained from 15% (vol/vol) glycerol stocks stored at -80oC. The stocks were thawed, and a loopful 
was streaked onto appropriate agar plates using an aseptic technique. Bacteria were initially streaked 
onto Columbia sheep blood agar (CBA) (Fort Richard Laboratories, Auckland, NZ) then sub-cultured 
onto Mitis-Salivarius agar (Fort Richard Laboratories, Auckland, NZ) and Mutans-selective medium 
(Fort Richard Laboratories, Auckland, NZ). All bacteria were incubated at 37ºC for 24 hours under 
anaerobic conditions in a Gas-Pak™ EZ Gas Generating Container System (Becton, Dickinson and 
Co., Sparks Maryland, USA).  
 






Strain  Gram Stain Growth conditions Role in endodontics 
S. mutans UAB159 Positive Facultative anaerobe Initiation in primary infection  
S. gordonii DL1 Positive Facultative anaerobe Initiation in primary infection 
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3.2 Selection and preparation of growth media  
3.2.1 Agar plates  
- 3.2.1.1 Columbia sheep blood agar  
  CBA is used for the isolation and cultivation of a wide variety of fastidious microorganisms. 
It was first developed by Ellner et al. (1966). Red blood cells from sheep provide the hemoglobin 
needed for detection of haemolysis and allow the differentiation between alpha and beta haemolytic 
species. Alpha-haemolytic Streptococcus spp. such as S. mutans or S. gordonii oxidise the iron in 
haemoglobin producing a greenish colour on blood agar. Beta-haemolytic species, such as E. faecalis 
cause complete lysis of red blood cells, producing a translucent zone clear of blood cells surrounding 
colonies. CBA was used to differentiate between S. mutans, S. gordonii, and possible bacterial 
contamination.  
- 3.2.1.2 Mitis-salivarius agar  
  Mitis-salivarius agar is used for selective isolation of certain species of streptococci and 
enterococci. The inclusion of crystal violet dye and 1% potassium tellurite inhibits the growth of most 
gram-negative b acilli and gram-positive bacteria except streptococcal and enterococcal species. The 
trypan blue is absorbed by Streptococcus colonies, producing a blue colour with a frosted appearance.    
- 3.2.1.3 Mutans selective agar  
  Mutans selective agar was developed for the isolation of S. mutans and is a modification of 
Mitis-salivarius agar containing 0.2 units/mL bacitracin with an increase in the sucrose concentration 
to 20% (w/v) (Emilson & Bratthall 1976; Gold et al. 1973). The optimal concentration of sucrose and 
bacitracin inhibits other streptococci without inhibition of S. mutans. Mutans selective agar was used 







3.2.2 Liquid medium 
- 3.2.2.1 Tryptic Soy Broth  
  Tryptic soy broth (TSB) (Difco Laboratories, Detroit, MI, USA) is an all-purpose liquid 
medium used for the enrichment and cultivation of a wide variety of microorganisms, especially for 
the preparation of inocula. TSB was prepared by dissolving 30 g in 1 L of distilled water, stirred with 
a magnetic stirrer. The solution was autoclaved at 121ºC for 20 min, allowed to cool, and stored at 
room temperature until required.  
 
3.3 Confirmation of species  
    As both Streptococcus species were sourced from the Department of Oral Sciences Culture 
Collection, it is assumed that each strain is accurate. Prior to experimental use, three to four colonies 
of S. mutans and S. gordonii were streaked onto Mutans-selective agar (Fort Richard Laboratories) 
and Mitis-salivarius agar (Fort Richard Laboratories) and incubated at 37oC for 24 hours in anaerobic 
conditions in a Gas-Pak™ EZ Gas Generating Container System (Becton, Dickinson and Co.). The 
visual appearance of the Streptococcus bacteria was confirmed by two experienced observers.  
 
3.4 Preparation of inocula  
  Cultures of S. mutans and S. gordonii were streaked onto CBA plates (Fort Richard 
Laboratories) and incubated at 37°C for 24 hours under anaerobic conditions to obtain isolated 
colonies. Two or three colonies were transferred aseptically into 3 mL TSB and incubated for 24 
hours. The overnight broth was harvested by centrifugation (11,500 x g for 5 min) and the supernatant 
removed. The pellet was resuspended in 5 mL TSB using a vortex mixer. The culture was adjusted to 
an optical density at 600 nm (OD600 nm) of 0.5. This contained approximately 5 x 107 colony forming 





3.5 Preparation of antimicrobial solutions  
3.5.1 Preparation of Auphen  
    Auphen was prepared according to the study by Block & Bailar Jr (1951). A solution of 1 g of 
1,10-phenanthroline in 10 mL of ethyl alcohol was added to a solution of 1 g of HAuCl4 solution in 
10 mL of ethyl alcohol, forming a yellow precipitate, [Au(phen)Cl2]Cl. The transformation was 
completed by heating the mixture for four hours on a steam-cone and the precipitate dried at 37oC for 
24 hours. Once dry, 4.833 mg of Auphen compound was solubilised in 10 mL of sterile deionised 
water to give a concentration of 1 mM. The solution was covered with aluminium foil and stored at 
room temperature until use.  
3.5.2 Preparation of calcium hydroxide  
  A saturated solution of calcium hydroxide (Ca(OH)₂) (Sigma-Aldrich®, St. Louis, MO, USA) 
was prepared by mixing Ca(OH)₂ powder (Sigma-Aldrich®) (16 mg) with sterile distilled water (10 
mL). The mixture was centrifuged at 3000 RPM (1077 x g) for 15 min to clarify the solution. The 
aqueous supernatant layer was filtered aseptically using a sterile 25 mm diameter 0.22 μm syringe 
filter (Millex®, Merck KGaA™, Darmastadt, Germany) into a sterile 15 mL Falcon® tube (Becton, 
Dickinson and Co., Maryland, USA). The pH of the saturated solution was found to be 12, using a pH 
meter. The saturated Ca(OH)₂ solution was prepared as required for subsequent experiments. 
3.5.3 Preparation of polymer gel  
   Poloxamer 407 (P407) (Sigma-Aldrich®, St. Louis, Missouri, USA) was prepared by the cold 
method described by Schmolka 1972. Solutions of P407 in the range of 15 - 35% (w/v) were prepared 
by slowly dissolving the required amount of P407 over 2 - 3 minutes in 5 mL sterile distilled water (2 
- 4°C) in 20 mL glass vials and stirred using a magnetic stirrer at 1500 RPM for 1 hour. The stirrer 
was removed, and the solution stored at 2 - 4°C for 24 hours to ensure complete dissolution. The 
following tests were carried out at 24 h, 48 h, 72 h and at 7 days with the vials refrigerated at 2 - 4°C 
for at least 24 hours between each test. Multiple independent tests were carried out in triplicate over 
separate days to produce representative results.  
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Figure 3.5.3: Photograph of prepared 25% (w/v) Poloxamer 407 gel  
3.5.3.1 Tube inversion method  
  Gelation of 1 mL samples between 15 - 35%  at 37°C was determined by inverting the vial to 
assess formulation flow. Samples were discarded if gelation had not occurred.  
3.5.3.2 Injectability of gel 
   P407 gel samples were stored at 2 – 4oC to induce a liquid state. An aliquot of each sample 
was pipetted into separate 3 mL syringes (Becton, Dickinson and Co., Maryland, USA) and stored at 
37oC for 24 hours to induce gelation. Four open-ended blunt syringe needles with different diameter 
sizes (Becton, Dickinson and Co., Maryland, USA), as shown in Table 3.5.3.2, were tested to assess 
their ability to inject 1 mL aliquots of various concentrations P407 samples at 37°C.  
Table 3.5.3.2 Dimensions of tested syringe needles 
Size Outer diameter Inner diameter 
23- gauge 0.63 mm 0.33 mm 
25-gauge 0.53 mm 0.26 mm 
27-gauge 0.42 mm 0.21 mm 
30-gauge 0.32 mm 0.16 mm 
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3.5.3.3 In vitro gel stability studies  
  An assessment of the dissolution rate of P407 gel was determined using a membrane 
dissolution model. Previous tube-inversion and injectability studies indicated that 20, 25 and 30% 
(w/v) concentrations were suitable. Samples (1 ml) of 15-35% (w/v) P407 solution were incubated at 
37°C to induce gelation. The initial weight was recorded. PBS (100 ml) was pre-warmed to 37°C and 
slowly added to the surface of the gel. The PBS was removed at pre-determined time intervals, the 
weight of the remaining gel recorded and the percentage gel weight loss calculated. This was repeated 
until the gel completely dissolved. The dissolution profile was obtained by plotting the cumulative 
weight of the dissolved P407 gel against time. The ideal dissolution time required was 6 - 7 days, 
mimicking the medication period between root canal appointments. 
3.5.3.4 In vitro release of Auphen from P407 gel  
  In vitro release of Auphen from the P407 gel was assessed over a 7-day period. At 2 – 4oC, 1 
mM aqueous Auphen was combined with P407 gel to 25% (w/v) in a 20 mL glass vial and stirred 
using a magnetic stirrer (1500 RPM) for 24 hours to ensure complete dissolution. The sample was 
stored at 2 - 4oC to maintain a liquid state. Auphen-loaded P407 gel (1 mL) was dispensed into an 
Eppendorf tube and incubated at 37oC to induce gelation. One hundred microlitres of PBS pre-
warmed to 37°C was slowly added to the surface of the gel. At pre-determined time intervals, the 
liquid phase was removed and pipetted into an Eppendorf tube. 
  The samples were subjected to analysis through inductively coupled plasma-mass 
spectroscopy (ICP-MS) (The Centre for Trace Elements Analysis, University of Otago). Samples 
were diluted into the analytical range in 1% (v/v) HCl, 1% (v/v) HNO3 and 0.02% (w/v) thiourea and 
gold content measured using an Agilent 7900 quadrupole ICP-MS (Agilent Technologies®, Santa 
Clara, California, USA). The ICP-MS was tuned to minimize interferences, instrumental drift and 
possible matrix effects through the addition of bismuth. Calibration standards were determined 
according to the ‘High Purity Standards’ gold standard using NIST® Traceable Calibration (Sure 
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Controls Inc®, Greenville, Wisconsin, USA). The method was validated by spiking known additions 
of gold into the saline matrix of the samples with recovery shown to be ≈ 99%.  
   
3.6 Antimicrobial activity of Auphen 
3.6.1 Minimum inhibitory concentration  
  An Auphen stock solution (1 mM) was serially diluted in a 96 well microtitre plate (Greiner 
Bio-One GmbH) to give concentrations in the range of 0.001 – 1 mM. Preparation of each well involved 
pipetting 20 μL of Auphen, and adding double strength TSB (100 μL), sterile distilled water (70 μL) 
and the previously prepared inoculum (10 μL). Separate microtitre plates (Greiner Bio-One GmbH) 
were prepared for each microorganism (See Appendices A). The positive control wells substituted 
sterile water in place of the Auphen. The number of bacteria per well was estimated to be 5 x 107 CFU. 
The wells at the periphery of each plate contained sterile broth and sterile water to serve as a negative 
(growth) control but also to minimise dehydration of the plate during incubation. The plates were sealed 
in plastic sandwich bags. The initial OD600  was determined using a microtitre plate reader (Synergy 2, 
BioTek®, Vermont, USA) and plates then incubated at 37°C for 24 h under anaerobic conditions 
without shaking.  
  After incubation, cultures were resuspended using a vortex mixer. The negative (growth) 
control wells were checked for clarity to ensure the absence of growth, while the positive control 
wells were checked for turbidity to ensure growth had occurred. All wells were assessed, and the MIC 
read as the lowest concentration that inhibited the growth of bacteria. This was confirmed 
quantitatively by scanning the microtitre plates using a plate reader and determining the culture 
density (OD600).  
  This procedure was repeated using Auphen-loaded P407 gel, with Auphen concentrations in 
the range of 0.001 – 1 mM, to determine the MIC. Separate microtitre plates (Greiner Bio-One 
GmbH) were prepared for each microorganism (Appendix A). Multiple independent tests were 
performed over separate days for aqueous Auphen and Auphen-loaded P407 gel, and representative 
results shown.  
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3.6.2 Minimum bactericidal concentration  
  Aliquots (20 μL) from the wells without visible growth were plated onto CBA (Fort Richard 
Laboratories) to determine the MBC. The agar plates were incubated in anaerobic conditions (37oC) 
for 24 hours and assessed for growth. The lowest concentration from which no colonies developed 
was determined to be the MBC. 
 
3.6.3  Bactericidal contact time  
  Microtitre plates (Greiner Bio-One GmbH) were prepared as per the MIC test. Per strain and 
in triplicates, the determined MBCs of aqueous Auphen and Auphen-loaded gel were dispensed in the 
corresponding microtitre well. Sodium hypochlorite (Dentalife® Endosure Hypochlor™, Victoria, 
Australia) and calcium hydroxide (Sigma-Aldrich®) were also tested.  
  At pre-determined incubation time intervals; 0, 15, 30, 45, 60, 75 minutes; 50 μL from each 
well was spotted onto CBA (Fort Richard Laboratories) and incubated at 37oC for 24 hours. The 
minimum amount of time required for complete bacterial death was recorded.  
3.7 Susceptibility testing of bacteria  
  Based on determined MBC values and release studies, P407 gel was loaded with various 
concentrations of Auphen and tested for its bactericidal effect on planktonic cells and reduction of 
biofilm biomass. Multiple independent tests were performed over separate days for aqueous Auphen 
and Auphen-loaded P407 gel, and representative results shown. 
3.7.1 Planktonic bacteria  
  Auphen solution was serially diluted in the range of 0.01 – 1 mM. The 25% (w/v) P407 gel 
was prepared with Auphen concentrations ranging between 0.01 – 1 mM. The P407 gel was added to 
each prepared Auphen concentration to a final concentration of 25% (w/v).  
  Six microtitre plates (Greiner Bio-One GmbH) were prepared for each bacterial strain, three 
for the Auphen-loaded gel and three for aqueous Auphen formulation and incubated for up to 72 
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hours. Plates were prepared as shown in Appendix B. Planktonic bacteria were similarly tested against 
calcium hydroxide (Sigma-Aldrich®) and 4% NaOCl (Dentalife®). 
3.7.2 Monospecies biofilm  
3.7.2.1 Growth of bacterial biofilms 
  Bacteria were inoculated in 4 mL of TSB and grown to a stationary phase overnight. Bacterial 
suspension (1 mL) was adjusted to OD600 = 0.5 (~5 x 107 CFU/mL) and diluted 1:100 (5 x 105 
CFU/mL) in TSB + 1% (w/v) sucrose. An inoculum of 180 μL of the culture was added to 
corresponding wells of a 96 well microtitre plate (Greiner Bio-One GmbH). As a negative (growth) 
control, wells at the periphery of the microtitre plate contained sterile TSB (180 μL). Plates were set 
up as shown in Appendix C. 
  The sterile plastic lids were replaced on the microtitre plates and the plates incubated at 37°C 
for 24 hours. Planktonic microbes were removed after 12 hours by extracting 150 μL of the growth 
medium and replacing it with sterile TSB + 1% sucrose (150 μL).  
 After incubation for 24 hours, the growth medium was removed by immersing the microtitre 
plates in distilled water (4L) at 2 – 4oC. The microtitre plates, wells facing up, were carefully 
submerged at 45o and moved gently from side-to-side, carefully removed, inverted and tapped to 
remove any liquid. This was repeated three times for each plate. Each plate was placed well-side 
down onto a paper towel to drain for 15 minutes. The plates were then flipped, well-side up, and air-
dried for another 15 minutes.  
3.7.2.2 Exposure of biofilm to antimicrobials  
  Auphen solution was serially diluted to concentrations in the range of 0.01 – 1 mM. P407 
gel was prepared as previously described and added to each Auphen preparation to a final 
concentration of 25% (w/v) P407. Auphen gel preparations (100 μL) were added to washed wells 
with attached biofilms and incubated for 24 hours at 37oC. Biofilms grown in microtitre plates were 
exposed to Auphen-P407 preparations, P407 gel, aqueous Auphen, saturated Ca(OH)2 solution and 
4% NaOCl (Dentalife® Endosure Hypochlor™). Sterile PBS and sterile TSB served as controls. 
The positive control wells substituted sterile water for the Auphen compound. Microtitre plates with 
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biofilms were incubated anaerobically at 37°C. After each exposure period the effects of the 
substances on the biofilm were assessed using the resazurin assay (below).  
3.7.2.3 Resazurin metabolic assay 
  Resazurin 98% (BDH Chemicals® Ltd, Philadelphia, USA) was dissolved in PBS (pH 7.4) 
to 0.15 mg/mL. The solution was filtered through a 0.2 μm filter (Millex®, Merck KGaA™) into a 
sterile, light protected Falcon® tube (Becton, Dickinson and Co.) and stored at 4oC. 
  96-well microtitre plates (Greiner Bio-One GmbH) were prepared for each microorganism 
containing 100 µl/well as previously described (Appendix E). After incubation for 24 hours, the 
growth medium was removed by washing the microtitre plates in 4 litres of distilled water at 2 – 
4oC as described previously.  
  TBS + 1% glucose (100 μL) and 20 µl of resazurin solution were added to each well and 
the fluorescence was recorded at intervals using a plate reader (Synergy 2, BioTek®) at 560 nm 
excitation and 600 nm emission filter settings after 20 min, 40 min, 60 min, and again after 6 and 24 
hours (Pettit et al. 2005). Plates were wrapped in foil and stored in a 37oC incubator between 
fluorescence determination. The highest fluorescence reading was recorded. Treatment efficacy was 
calculated as the percentage reduction in fluorescence relative to the positive control (sterile water).  
3.8 Statistical analysis  
  Continuous variables are presented as means and standard deviation from the OD results, 
calculated using Microsoft Office Excel software. Statistical analysis was carried out using SPSS 
(IBM® SPSS® Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp). Independent-samples 
t-tests were used to compare the means between two groups. One-way analysis of variance (ANOVA) 
with post-hoc Tukey’s honest significant difference (HSD) tests compared the effects of 





Chapter 4: Results  
4.1 Poloxamer 407  
4.1.1 Formulation characterisation  
  P407 containing various concentrations of Auphen were successfully prepared by the cold 
method (Schmolka 1972). All the P407 formulations ≥ 20% (w/v) formed gels within two minutes at 
37°C. A 25% (w/v) P407 gel formulation observed ideal viscosity and injectability properties at room 
(24oC) and body temperatures (37oC). Concentrations ≥ 30% (w/v) were too viscous at room 
temperature and excluded from the study. At P407 concentrations ≤ 20% (w/v), formulations existed 
as a free-flowing liquid at body temperature (37oC), which were not suitable to be syringed, and were 
also excluded from the study.  
4.1.2 Table of syringability 
  The P407 gel at a concentration of 30% (w/v) could not be injected through the 27- and 30-
gauge needles and were excluded from the study. Both 20% (w/v)  and 25% (w/v) formed into a gel 
after the incubation period and were injectable from all four syringe tips (Table 4.1.2).  
                     P407 
                           conc. 
 Needle size 
15% (w/v) 20% (w/v) 25% (w/v) 30% (w/v) 
23- gauge + + + + 
25-gauge + + + + 
27-gauge + + + (-) 
30-gauge + + + (-) 





4.1.3 In vitro gel stability   
  The 20% (w/v) P407 gel formulation completely dissolved within three days and was 
excluded from the study as it did not meet the required 6-day dissolution profile (Figure 4.1.3a). The 
25% (w/v) P407 gel without Auphen retained 75%, 60%, and 47% mass after 24 , 48, and 72 hours 
respectively (Figure 4.1.3b).  P407 25% (w/v) gel loaded with Auphen retained 84%, 70%, and 54% 
mass after 24, 48, and 72 hours respectively (Figure 4.1.3c). The Auphen-loaded gel completely 
dissolved after 168 hours (approximately 7 days) compared to 144 hours for the 25% (w/v) gel alone, 
indicating that Auphen does not significantly alter the stability of P407. In fact, a minor increase in 
the stability of P407 was recorded.  
 


















20% (w/v) P407 Gel
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Figure 4.1.3b 25% (w/v) P407 gel dissolution over a 7-day period. 




































25% (w/v) P407 Gel + Au [1 mM]
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Figure 4.1.3d. 25% (w/v) P407 gel dissolution over 7-days. 8 – 18% of the mass dissolved after each 24-hour 
period. 
 
4.1.4 In vitro gel release  
  The concentration of Auphen released from the samples was determined by inductively-
coupled plasma-mass spectroscopy (ICP-MS). The control sample (1 mM aqueous-Auphen) contained 
a concentration of 0.84 mM of the Auphen compound (± 0.005 mM). The mean concentration of 
solubilised Auphen within the removed supernatant after 24, 48 and 72 hours was 0.26 mM, 0.244 
mM and 0.218 mM respectively. The release of Auphen followed a linear downward gradient, 
indicating a steady release of Auphen from the P407-gel over the 7-day period, as shown by the 












(%) Gel dissolved in 24 hour period
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Figure 4.1.4 Auphen concentration (mM) released to the aqueous phase over 7-days and measured by ICP-MS. 
The trendline indicates a downward linear release over the 168 hours. 
 
4.2 MIC and MBC of aqueous Auphen against planktonic bacteria 
  Aqueous Auphen displayed bacteriostatic activity against both Streptococcus species tested.  
Aqueous Auphen at 0.1 mM completely inhibited the growth of both Streptococcus species (MIC), 
with turbidity not observed at this concentration after 24 hours of incubation. Both Streptococcus 
species tested were consistently susceptible to Auphen at an MBC of 0.5 mM. This is consistent with 
the literature, as MBCs > MICs.  
Table 4.2 MIC and MBC values of aqueous Auphen. 
Strain MIC of Auphen (mM) MIC of Auphen (mM)  
Streptococcus gordonii DL1 0.1 0.5  





























4.2.1 Streptococcus gordonii   
 Exposure to Auphen at concentrations ≤ 0.05 mM resulted in significantly more growth of S. 
gordonii compared to concentrations ≥ 0.1 mM (p < .01) (See Appendix D).  
 
Figure 4.2.1 Growth of S. gordonii after 24 hours exposure to varying concentrations of aqueous Auphen. The 
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4.2.2 Streptococcus mutans 
  A significant reduction in S. mutans growth was observed after exposure to 0.5 mM compared 
to ≤ 0.1 mM Auphen (p < 0.05) (See Appendix F).  
Figure 4.2.2 Growth of S. mutans after 24 hours exposure to varying concentrations of aqueous Auphen. The 
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4.3 MIC and MBC of Auphen-loaded P407 gel on planktonic bacteria 
  P407 loaded with Auphen exhibited bacteriostatic activity against the two test strains. The 
MICs of both S. gordonii and S. mutans were identical to those of aqueous Auphen (See Appendix D) 
after 24 hours incubation (Table 4.3). As with the aqueous Auphen, both species of Streptococcus 
experienced complete death at 0.5 mM (MBC). 
 

















Strain MIC of Auphen (mM) MBC of Auphen (mM)  
Streptococcus gordonii DL1 0.1 0.5  
Streptococcus mutans UAB159 0.1 0.5  
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4.3.1 Streptococcus gordonii  
  The growth of S. gordonii was significantly greater when exposed to Auphen-loaded P407 gel 
concentrations ≤ 0.05 mM compared to ≥ 0.05 mM aqueous Auphen (p < 0.05) (See Appendix E).  
Figure 4.3.1 Planktonic growth of S. gordonii after 24 -hour exposure to varying concentrations of Auphen-




































Concentration of Auphen (mM) in P407 gel 
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4.3.2 Streptococcus mutans  
  The growth of S. mutans was significantly greater when exposed to Auphen-loaded P407 gel 
concentrations  ≤ 0.1 mM compared to ≥ 0.05 mM (p < 0.01) (See Appendix F).  
 
Figure 4.3.2 Planktonic growth of S. mutans after 24-hour exposure to varying concentrations of Auphen-



































Concentration of Auphen (mM) in P407 gel 
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4.4 Time-kill Assay  
   After one hour, both S. mutans and S. gordonii were completely killed by both the aqueous-
Auphen and the Auphen-loaded gel at 25% (w/v).   
 
Table 4.6 Time required for complete bacterial elimination using aqueous Auphen and Auphen-loaded P407 
gel. 
4.5 Susceptibility of planktonic bacteria exposed to Auphen over 72 hours 
  The antimicrobial activity of Auphen loaded P407 gel was comparable to the corresponding 
aqueous preparations. The aqueous Auphen and Auphen-incorporated P407 gel ( ≥ 0.1 mM) displayed 
similar antimicrobial ability to NaOCl (4%) control and was significantly more effective than 
saturated calcium hydroxide control in bacterial killing over the 72-hour (p < 0.01) (Figures 4.5.1a – 
4.5.2b).  
4.5.1 Streptococcus gordonii 
  More growth of S. gordonii was generated in P407 gel (without Auphen) than either sterile 
water or Ca(OH)2, but not statistically significant (Figure 4.5.1b). Both the aqueous Auphen and 
Auphen-incorporated gel formulations generated near identical growth when S. gordonii was exposed 
for 24, 48 and 72 hours (P < 0.01). Auphen concentrations ≥ 0.1 mM in both gel and aqueous form 
inhibited growth when compared to concentrations ≤ 0.1 mM (p < 0.05) (Figure 4.7.1a,b). The tested 
samples of both aqueous Auphen and Auphen-loaded gels ≥ 0.1 mM displayed bacterial growth 
comparable to NaOCl (4%) (Figure 4.5.1a,b).   
Strain Time until complete bacterial death 
Streptococcus gordonii DL1 1 hour 
Streptococcus mutans UAB159 1 hour 
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   Calcium hydroxide did not inhibit the growth of S. gordonii, with OD values comparable to 
that of the sterile water control. After 48 hours, the growth in the presence of calcium hydroxide 
increased (Figure 4.7.1a, b). Auphen in both aqueous and gel forms (≥ 0.01 mM) resulted in 
statistically significant reduction in growth compared to Ca(OH)2 (p < 0.01) (Figure 4.5.1a, b).   
4.5.2 Streptococcus mutans 
  As per the S. gordonii planktonic experiments, aqueous Auphen and Auphen-loaded gel 
medicaments with equivalent concentrations produced similar effects against S. mutans (P < 0.01). 
Auphen concentrations ≥ 0.1 mM in both gel and aqueous forms resulted in significant reductions in 
bacterial growth when compared to ≤ 0.1 mM (Figure 4.5.2a,b). Sodium hypochlorite (4%) displayed 
complete bacterial death when tested against S. mutans. Both aqueous Auphen and Auphen-loaded 
gels (≥ 0.1 mM) resulted in bacterial growth comparable to NaOCl (4%) over the 72 hour period, 
indicating similar antimicrobial potential (Figure 4.5.2a,b).  
  Auphen-loaded gel (0.01 mM) supported sustained bacterial growth over 72 hours, with 
culture densities comparable to those samples without Auphen (positive controls) and Ca(OH)2 
(Figure 4.5.2b). Aqueous Auphen at 0.01 - 0.05 mM, and Auphen-loaded gel at 0.05 mM, resulted in 
reduced bacterial growth compared to the positive control (sterile water).  
  P407 gel without Auphen generated more growth than either the positive control (sterile 
water) or Ca(OH)2 (p < 0.01) (Figure 4.5.2b). Calcium hydroxide inhibited bacterial growth of S. 
mutans when exposed in the first 24 hours, but was comparable to the positive control (sterile water) 




Figure 4.5.1a: Effect of aqueous Auphen (0.1 – 1 mM) and controls (calcium hydroxide, sterile water and 

























Sterile water AqAu 0.01 mM AqAu 0.05 mM AqAu 0.1 mM
AqAu 0.5 mM AqAu 1 mM Ca(OH)2 NaOCl (4%)
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Figure 4.5.1b: Effect of Auphen-loaded P407 gel (0.1 – 1 mM) and controls (calcium hydroxide, sterile water 



























Gel 0 mM Gel 0.01 mM Gel 0.05 mM Gel 0.1 mM




Figure 4.5.2a: Effect of aqueous Auphen (0.1 – 1 mM) and controls (calcium hydroxide, sterile water and 


























Sterile water AqAu 0.01 mM AqAu 0.05 mM AqAu 0.1 mM





Figure 4.5.2b: Effect of Auphen-loaded P407 gel (0.1 – 1 mM) and controls (calcium hydroxide, sterile water 



























Gel 0 mM Gel 0.01 mM Gel 0.05 mM Gel 0.1 mM
Gel 0.5 mM Gel 1 mM Ca(OH)2 NaOCl (4%)
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4.6 Biofilm viability – Resazurin assay  
All concentrations of aqueous Auphen and Auphen-loaded gels with ≥ 0.05 mM resulted in 
lowered metabolism, indicating partial or complete biofilm inhibition. All samples (except sodium 
hypochlorite) exhibited visible biofilm/debris adhering to the base of the well after rinsing with 
distilled water. Sodium hypochlorite (4%) exhibited complete bacterial cell death and biofilm 
breakdown in both species tested. 
  In all the tested samples, the percentage reduction recorded from identical concentrations of 
Auphen-loaded P407 gel and aqueous Auphen were comparable (Figure 4.6.1a – 4.6.2d). This is 
supported by the in vitro release studies (Table 4.1.4) and antimicrobial tests on planktonic bacteria 















4.6.1 Streptococcus gordonii 
Aqueous Auphen and Auphen-loaded gels (≥ 0.1 mM) resulted in ≤ 13.3% reduction in 
metabolic activity, indicating low biofilm viability after 24-hours (Figure 4.6.1 b, c). Calcium 
hydroxide reduced the metabolic activity of S. gordonii (21.9% ± 11.4), but did not completely 
eliminate the biofilm (Table 4.6.1a). 
  The P407 gel (98.9% ± 8) and 0.01 mM Auphen-loaded gel (99.3% ± 16.1) were ineffective 
against S. gordonii biofilms. A significant reduction in biofilm viability was documented from 
Auphen samples ≥ 0.1 mM in both aqueous (73.9% reduction) and gel states (86.8% reduction). 
Auphen-loaded gel (1 mM) (13.3% ± 4.7) and aqueous Auphen (1 mM) (11.3% ± 5.2) exhibited a 
slight increase in fluorescence compared to 0.5 mM samples, however the results were not statistically 
significant (Figure 4.6.1c).  
 
 
Table 4.6.1a: Reduction of resazurin following exposure of control agents to S. gordonii biofilm for 24 hours. 












































Table 4.6.1b: Reduction of resazurin following exposure of Auphen-loaded gel (0.01 – 1 mM) to S. gordonii 










































































Table 4.6.1c: Reduction of resazurin following exposure of aqueous Auphen (0.01 – 1 mM) to S. gordonii 











































































Figure 4.6.1d: S. gordonii biofilm exposed to varying concentrations of aqueous Auphen (0.01-1 mM), Auphen-loaded P407-gel (0.01 – 1mM) and controls. Fluorescence 















































4.6.2 Streptococcus mutans 
 
 Aqueous Auphen and Auphen-loaded gels (≥ 0.1 mM) showed less than 14.5% reduction in 
metabolic activity indicating low biofilm viability after 24 hours (Figure 4.6.2c). The P407 gel alone 
was ineffective against S. gordonii biofilms (92.1% ± 8.1). As with the S. gordonii tested samples, a 
significant reduction in biofilm viability was recorded between 0.01 mM and 0.1 mM Auphen 
samples in both aqueous and gel forms. Similarly, the 1 mM samples of Auphen-loaded gel (14.5% ± 
9.4) and aqueous Auphen (11.3% ± 10.7) recorded a slight increase in recorded fluorescence 
compared to 0.5 mM samples (Figure 4.6.2c).  
  The S. mutans biofilm was observed to be more resistant to calcium hydroxide (28.9% ± 10.7) 
compared to S. gordonii biofilms (p < 0.01) (Table 4.6.2a). 
 
Table 4.6.2a Reduction of resazurin following exposure of control agents to S. mutans biofilm for 24 hours. 













































Table 4.6.2b. Reduction of resazurin following exposure of Auphen-loaded gel (0.01 – 1 mM) to S. mutans 
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Table 4.6.2c. Reduction of resazurin following exposure of aqueous Auphen (0.01 – 1 mM) to S. mutans biofilm 
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Figure 4.6.2d: S. mutans biofilm exposed to varying concentrations of aqueous Auphen (0.01-1 mM), Auphen-loaded P407-gel (0.01 – 1mM) and controls. Fluorescence 















































Chapter 5:  Discussion 
 
 The aim of this study was to assess the antimicrobial ability of Auphen on two common 
endodontic microorganisms. In vitro, this involved development of a sustained release hydrogel 
suitable for intracanal administration, as a vehicle for the delivery of Auphen. The antimicrobial 
ability of the Auphen-loaded P407 gel was compared to aqueous Auphen and common endodontic 
antimicrobial agents, calcium hydroxide and sodium hypochlorite, in both planktonic and biofilm 
models.   
5.1 Poloxamer 407 gel  
 In pharmacokinetics, a ‘loading dose’ or ‘initial dose’ is administered followed by 
‘maintenance’ dosages to achieve a steady-state concentration of the drug within the targeted tissue 
over the therapeutically effective medication period (Gilbert et al. 1986). Ongoing research continues 
to improve the efficiency of administered drugs through combinations of delivery vehicles, such as 
polymer gels (Paavola et al. 1998). The incorporation of either hydrophilic or lipophilic additives into 
pharmaceutical formulations is a common practice for protracting the release of drugs and thereby 
prolonging its presence within the tissues (Ju et al. 2013). Thermo-responsive gels, such as Poloxamer 
407, can be administered directly to the targeted site, increasing the drug residence time (Bruschi et 
al. 2007; Fabri et al. 2011; Pereira et al. 2013).  
  P407 has been tested for the delivery of antibiotics (Esposito et al. 1996; Simeone et al. 2017; 
Veyries et al. 1999; Yang et al. 2016; Zhang et al. 2002), anti-inflammatory drugs (Jensen et al. 2019; 
Miyazaki et al. 1995; Newa et al. 2008), anti-cancer drugs (Amiji et al. 2002; Baldassari et al. 2018; 
Ju et al. 2013; Miyazaki et al. 1984; Saxena & Hussain 2012; Zhang et al. 2014), anti-viral drugs 
(Jindal & Mehta 2015), anti-platelet treatment (El-Laithy et al. 2019), anaesthetics such as lidocaine 
(Chen-Chow & Frank 1981; Ricci et al. 2002; Ricci et al. 2005; Zanon et al. 2019) and biologically 
active proteins/peptides such as interleukin-2 (Johnston & Miller 1985), melanotan-I (Bhardwaj & 
Blanchard 1996), and urease (Fults & Johnston 1990; Pec et al. 1992). These studies report that P407 
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hydrogels possess desirable pharmacological properties, including being non-toxic and safe to use in 
human tissues. Therefore, P407 hydrogels was deemed as a suitable delivery mechanism for Auphen. 
  For the current study, the concentration of P407 was dependent on the hydrogel existing in an 
aqueous state at room temperature (24oC) and in gel-form at body temperature (37oC). At room 
temperature, P407 can be injected to flow into the entire complex root canal system and subsequently 
form a gel once the transition temperature (Tsol-gel) has been reached. Micelle formation and gelation at 
temperatures equal to and below room temperature, create difficulties in manufacturing, handling and 
clinical application. On the other hand, if the Tsol-gel is ≥ 37oC, the P407 formulation will remain in 
liquid form within the application site (root canal system) and drain through the apex into the 
periapical tissues, leading to poor drug efficacy. To determine the ideal formulation for this in vitro 
study, concentrations of P407 ranging from 15 to 30% (w/v) were tested. Below 20% (w/v), P407 
formulations remained aqueous at body temperature. Formulations of 20% (w/v) P407 gel retained the 
desired Tsol-gel properties, but dissolved within 72 hours, confirmed by other P407 gel studies (Chi & 
Jun 1991; El Gendy et al. 2002; Aggarwala et al. 2016). An increase in the concentration of P407 
generates shorter inter-micellar distance and greater cross-links between micelles (Schmolka 1972). 
The shorter distance between micelles leads to an increase in viscosity and rigidity that will slow the 
rate of dissolution and drug-release (Schmolka 1972). As such, a P407 concentration of 25% (w/v) 
retained the ideal Tsol-gel properties required to facilitate application and injection of Auphen into a 
root canal system. 
  
  P407 gels consist of high concentrations of aqueous channels which allow the incorporated 
solute to be released (Dumortier et al. 2006). The size of the aqueous channels, the arrangement of the 
solute within the aqueous phase, and the micro-viscosity of the extra-micellar fluid affects the release 
of the drug (Chen-Chow & Frank 1981; Rassing & Attwood 1982). At low temperatures (≈ 4oC),  
aqueous channels and small micellar subunits form within the P407 gel, releasing greater 
concentrations of solute. At higher temperatures, micellar desolvation and swelling gives rise to large 
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micelles that increase the overall viscosity of the gel due to the formation of a dense cross-linked 
network, reducing the release of the solute (Alexandridis & Hatton 1995; Chen-Chow & Frank 1981; 
Veyries et al. 1999). Release of the solute also occurs via gel dissolution. P407 gel dissolution 
involves the hydration of water-insoluble side groups that are converted to water-soluble polymers as 
a result of ionisation, protonation, or hydrolysis of the groups, and is controlled by the surface 
hydration rate (Gombotz & Pettit 1995). In the current study, in vitro stability and release profiles 
were conducted to determine the efficiency of P407 gel as a drug delivery vehicle. Studies testing 
P407 formulations have used the same ‘membraneless’ or direct contact dissolution model adapted in 
this study (Bhardwaj & Blanchard 1996; Chen-Chow & Frank 1981; Johnston & Miller 1985; 
Aggarwala et al. 2016). The advantage of this model is that the gel formulation is directly in contact 
with the PBS, and the released agent (Auphen) can be readily measured.  
 
  The addition of a drug can change gel properties. P407 varies in the TSol-gel once a drug has 
been incorporated. The added drug can also interfere with the gelation process (Gilbert et al. 1987; 
Ricci et al. 2002; Vadnere et al. 1984). In the current study, incorporation of Auphen (1 mM) with the 
P407 gel (25% w/v) did not affect the overall gel stability or the rate of dissolution. In fact, the 
incorporation of Auphen improved P407 gel stability, completely dissolving 24 hours after the P407 
gel without Auphen incorporated. Furthermore, there was a linear release of Auphen from the gel over 
the pre-determined seven-day clinical medication period, confirming the first and second hypotheses. 
1) Auphen incorporated into a P407 matrix is stable and suitable as an intracanal delivery system.  
2) Auphen is released over a clinically effective period from P407 gel. 
 
  The Auphen release profile correlated with the dissolution rate of the P407 gel. The 
dissolution of the gel did not deactivate or degrade the metallo-drug during the medication period, as 
shown by the ICP-MS analysis. Therefore, the drug availability of Auphen in an aqueous phase is 
comparable when incorporated into P407-gel, but with a prolonged drug-release period. As previously 
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discussed, the aqueous channels within the P407 gel provides passage for drug release (Bhardwaj & 
Blanchard 1996; Moore et al. 2000), however there are no reports indicating how Auphen is 
incorporated into the P407 gel nor its mechanism of release.  
  Hydrogels, such as P407, have been shown to possess antimicrobial properties due to the 
presence of a surfactant (Takáts et al. 2001; Veyries et al. 1999). However, the current study 
demonstrated that P407 gel alone supported microbial growth, comparable to the effect of water. On 
the other hand, the antimicrobial ability of Auphen (0.01 – 1 mM) in either aqueous or gel form was 
evident in susceptibility tests involving planktonic bacteria over 72 hours and mono-species biofilms 
supporting the third and fourth hypotheses.  
3) Planktonic cultures of bacteria are susceptible to Auphen-loaded P407 gels. 
4) Auphen-loaded P407 gel demonstrate antimicrobial activity against mono-species biofilms.  
 
  The antimicrobial effectiveness of drugs incorporated into P407 gel has been reported 
(Esposito et al. 1996; Mengi & Deshpande 1992; Aggarwala et al. 2016), but this is the first study to 
successfully incorporate a metallo-drug. Further testing is required against other common endodontic 
pathogens prior to clinical application as an intracanal medicament for root canal treatment. 
5.2 Antimicrobial ability   
   Streptococcus species have been observed in the initiation and progression of endodontic 
infections (Love 1996; Love et al. 2000), and were therefore involved in this study. S. gordonii and S. 
mutans are often present in the oral environment, implicated as early colonisers of dental plaque 
(Jenkinson & Lamont 1997; Nyvad & Kilian 1987). Streptococci also have the potential to egress 
within the confines of dentinal tubules, instigating a pulpal response (Love & Jenkinson 2002; Love et 
al. 1997). Similar to dental plaque formation, Streptococcus species provide additional binding sites 
for other microorganisms, forming a potentially virulent biofilm (Svensäter & Bergenholtz 2004).  
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  The current study demonstrates that aqueous Auphen and Auphen-loaded gel formulations 
inhibit growth of both streptococcal species in a planktonic state, validating the third hypothesis. Both 
S. gordonii and S. mutans recorded the same MIC and MBC in both aqueous and gel forms. At 
concentrations  ≤ 0.1 mM, Auphen inhibited bacterial growth but colonies developed when cultured 
onto agar. Concentrations of Auphen ≥  0.5 mM produced complete bacterial elimination consistently. 
Based on these results, the antimicrobial effects of Auphen is dose-dependent, requiring a minimum 
of 0.5 mM and at least one hour of contact for complete planktonic killing.  
  Biofilms are highly resilient to antimicrobial attack, posing significant treatment obstacles 
that can lead to persistent disease following root canal treatment. Therefore, root canal medicament 
research has focussed on efficiently targeting resilient biofilm without damaging human tissues 
(Huang et al. 2011; Kolenbrander et al. 2010; Ricucci & Siqueira Jr 2010). The current in vitro study 
demonstrates that Auphen-loaded P407 gels has bactericidal effects against both tested mono-species 
biofilms. Auphen inhibited the growth of S. gordonii and S. mutans at concentrations as low as 0.01 
mM. When biofilms were exposed to either aqueous Auphen or Auphen-loaded gel at the MIC, 
fluorescence was generated, indicating low bacterial activity within the biofilm. Biofilms exposed to 
Auphen (1 mM) recorded a minor increase in fluorescence, possibly due to the accumulation of the 
gold compound within the biofilm. However, no colour change, from purple (resazurin) to pink 
(resorufin), was observed from these wells indicating minimal bacterial metabolic activity.  
  The most commonly used intracanal medicament, calcium hydroxide, also evidenced anti-
biofilm properties against both streptococci. However, complete biofilm eradication was not 
observed, though Auphen ≥ 0.1mM was more effective than calcium hydroxide. Calcium hydroxide 
requires direct contact with bacteria or, alternatively, a sustained active period releasing hydroxyl ions 
that increase the pH (up to 11.5) to breakdown the cellular components and kill microorganisms 
(Nerwich et al. 1993). Biofilms are composed of thick layers of synergistic bacteria protecting the 
biofilm. Bacteria towards the periphery of the biofilm have been shown to provide protection for 
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bacteria within the core. Bacteria confined within the core avoid direct contact and have a greater 
ability to survive the high pH environment created by calcium hydroxide (Baker et al. 2004), 
reflecting the observations. The results indicate that Auphen applied as either a solution or a gel is 
more effective than calcium hydroxide against mono-species biofilms, opposing the fifth hypothesis.  
5) Auphen-loaded P407 gel are comparable in anti-microbial efficacy to calcium hydroxide. 
  Studies have also investigated the ability of Auphen to target water and/or glycerol channels 
(Casini et al. 2018; de Almeida et al. 2017). Homology models have proposed possible interaction 
points for the gold complex, particularly the methionine residue within AQP3 and 7; and the thiol 
side-chain of cysteine residues (Martins et al. 2012). The highly charged centre of the Auphen 
complex has a specific attraction for the thiol groups of cysteine compared with other amino acids 
within the aquaporin channel (Graziani et al. 2017). The steric occlusion by Auphen within this pore 
induces a conformational change of the protein, leading to shrinkage of the channel and inhibition of 
its primary function (de Almeida et al. 2017). With enough pores occluded within a microorganism, 
cellular dysfunction and death will occur. But, for as much as we understand about the molecular 
mechanism, the biological effects remain largely unknown. Further research is required to confirm the 
mechanism by which Auphen exerts its antimicrobial ability on bacteria implicated in root canal 
treatment failure.  
5.3 Experiment design and limitations  
5.3.1 Membraneless dissolution model 
 A membraneless dissolution model was used to assess the stability and active agent release of 
Auphen-loaded P407 gels. As previously discussed, the release of a fraction of Auphen at the 
interface has been postulated to occur via diffusion through channels while the remainder is released 
during gel dissolution (Anderson et al. 2001). One potential source of error from this model is the 
removal of the receptor medium (PBS) from the Eppendorf tube prior to ICP-MS analysis. Precise 
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removal of PBS was required with minimal disturbance to the gel surface, however discerning 
between layers proved difficult.  
 Like the current research, most of the previous studies have used young biofilms (< 1 week), 
and therefore, the good results noted in the laboratory may not correlate well with the clinical reality. 
Biofilms within the root lumen can form over months to years, building virulent colonies that are 
strongly adhered to the dentine wall. Without dentine or dentine-substitute with aged biofilm growth, 
the current research is limited in its design.  
  Other limitations of the membraneless dissolution model are the possible variations during 
experimental set up. The P407 gel and receptor medium are influenced by the stirring speed and 
temperature, possibly leading to variable results, but errors were minimised by replicating the 
experiments in triplicates. It must be noted that preheating of the receptor medium does not mimic in 
vivo conditions but rather is employed for procedural standardisation (Dumortier et al. 2006).  
5.3.2 Supersaturation of Auphen   
 Within the limitations of this study, Auphen (1 mM) in a solution or gel, targeting planktonic 
bacteria within a microtitre plate resulted in a minor increase in absorbance (OD600nm) potentially 
indicating more live bacteria present. Higher concentrations of Auphen also caused a visual increase 
in the precipitation within the wells. Similarly, precipitate was also visible in the biofilm experiments. 
Samples (1 mM Auphen) were plated repeatedly over multiple days, with no bacteria cultured. The 
precipitation and minor increase in absorbance may be a result of interaction of Auphen with the 
culture media, interaction with the microbes, or may be influenced by the pH of the culture medium 
leading to oxidisation (Shaw III et al. 1980). Alternatively, the solution or gel may have reached a 
point of supersaturation of Auphen (≥ 0.5 mM), that after a period, settles at the base of the microtitre 
well. Further testing is required to determine the saturation concentration of Auphen when combined 
in a solution and in gel forms.   
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5.3.3 P407 dissolution 
   The use of P407 gel as a viscous vehicle for the antimicrobial Auphen has advantages within 
the root canal system. As the gel can be retained within the confines of the root canal space for 
extended periods of time, the dispersion of the drug into the periapical tissues is minimised, reducing 
the risk of cytotoxic tissue damage. The results of the stability tests indicate that Auphen-loaded P407 
gel exhibits high solubility when in contact with a liquid, dissolving within seven days after direct 
contact with PBS. This confirms the appropriateness of P407 gel as a carrier for the administration of 
Auphen within the root canal system.  
  In the biofilm model, the Auphen-loaded P407 gel did not completely degrade after 24 hours, 
requiring a rinsing protocol prior to biofilm viability analysis. Within the confines of the root canal 
space, exposure to fluids is generally minimal, with direct liquid contact associated with either the 
periapical tissue fluids or retained fluid within the dentinal tubules (Brännström 1986), in which case 
the gel should still readily dissolve. It is possible that the Auphen-loaded gels may be stable for longer 
periods of time within the root canal system compared to the in vitro model due to these limitations.  
5.3.4 Calcium hydroxide  
  Calcium hydroxide is the most commonly used root canal medicament due to its antimicrobial 
properties which is achieves by creating a high pH environment through the release of hydroxyl ions 
(Nerwich et al. 1993). Calcium hydroxide is readily available as a paste, syringed directly into the 
root canal. However, due to the paste dehydrating within the microtitre plate wells, a saturated 
solution of calcium hydroxide was utilised, possibly influencing the current outcomes. It must also be 
noted that variations exist in the concentrations and therefore the speed at which ionic liberation 
occurs of various available calcium hydroxide medicaments (Fava & Saunders 1999). Thus, the 




5.3.5 Resazurin assay  
  Resazurin has been used as a fast and simple cell metabolic assay (Carrillo‐Muñoz et al. 
2006; Palomino et al. 2002; Pettit et al. 2005; Wei et al. 2006). Resazurin assays are a valuable 
measurement for the ‘endpoint of cytotoxicity’ rather than as a kinetic measurement to monitor 
cellular growth (Pettit et al. 2005). The complete reduction of the blue resazurin yields pink resorufin, 
but reduction of resorufin produces colourless hydro-resorufin which is non-fluorescent (Erb & Ehlers 
1950; Palomino et al. 2002; Pettit et al. 2005). Reduction to the non-fluorescent product may lead to 
aberrant results in which living bacteria may produce a weak signal. Alternatively, dying 
microorganisms which are not able to sustain further reduction, may yield a high fluorescent signal. 
This phenomenon is enhanced by the long half-life of reduced resazurin (resorufin) which is very 
stable in the absence of cells. To avoid this error, the highest fluorescence was recorded at pre-
determined times during the first 24-hours.  
    The removal of the Auphen-loaded gel from the bottom of the microtitre plate after the 
antimicrobial period also posed standardisation difficulties. Rinsing the microtitre plate under running 
water may lead to sheer forces that may dislodge bonded biofilm from the well. To avoid this error, 
the test was run multiple times to confirm results.   
5.4 Future research  
  Targeting of AQP modulators by structurally diverse gold complexes, such as Auphen, has 
been confirmed by numerous studies, particularly in treating human diseases (Casini et al. 2009; 
Fricker 1996; Soveral et al. 2018). The occurrence of human side-effects when using gold-based 
compounds has been shown to require a large accumulation of the solute within the body (Clark et al. 
1989; Hofmann et al. 1986; Taukumova et al. 1999). The amount utilised in root canal treatment is 
minor, therefore side-effects are improbable. Future research should endeavour to identify and test 
more pharmaceutically relevant metallo-compounds that may be beneficial in root canal treatment.  
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  Biofilm communities within the oral microbiota comprise of a multitude of virulent 
microorganisms, communicating and competing for nutrients and resources (Dufour et al. 2010). 
Compared to a single species biofilm, multi-species biofilms are more resistant to antimicrobials 
(Burmølle et al. 2006; Kara et al. 2006; Leriche et al. 2003), possibly due to the increasingly complex 
extracellular polysaccharide matrix associated (Adam et al. 2002). With the antimicrobial ability 
confirmed from the current study, future research is now required to assess the ability of Auphen, and 
similar gold complexes, to kill clinically relevant multi-species, established biofilms.  
  The present study could be supported using confocal laser scanning microscopy (CLSM) and 
fluorescence-based live-dead viability assay. CLSM provides high resolution optical images from 
various depths of the sample using a laser beam and reconstructed with a computer (Paddock 1999). 
When used in conjunction with a viability assay, the CLSM images can differentiate between live and 
dead bacteria within different layers of cultured biofilms (Caldwell et al. 1992; Lawrence et al. 1991; 
Norton et al. 1998). For this study, an assessment of the biomass after the development of an 
established biofilm can provide details on bactericidal activity of Auphen-loaded P407 gel. The depth 
of penetration of Auphen within the biofilm may also be determined. It would also be beneficial to 
assess in an in vitro model, whether Auphen-loaded P407 gels can penetrate and kill bacteria located 
within dentinal tubules. The interaction between Auphen and dentine/enamel also needs to be 
established. 
  Poloxamer 407 gel is a promising delivery vehicle for the metallo-drug, Auphen. Future 
research should evaluate the rheological behaviour of Auphen-loaded P407 gel, and the exact release 
mechanism of the gold complex. The inclusion of a potential additive, such as Carbopol 934P 
(mucoadhesive agent) (Balakrishnan et al. 2015), may be considered to improve the physicochemical 
properties of the Auphen-loaded gel (Choi et al. 1999). P407 is regarded as a stable and non-toxic 
carrier (Garcia Sagrado et al. 1994; Henry & Schmolka 1989; Johnston & Miller 1985), however 
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future endodontic research is needed to assess the biocompatibility of P407 within the periapical 
tissues, including toxicity to cells.  
5.5 Conclusions 
  The metallo-drug, Auphen, was successfully incorporated into a thermo-responsive gel, 
Poloxamer 407. The current study demonstrated that aqueous Auphen and Auphen-loaded P407 gels 
have antimicrobial ability against planktonic Streptococcus and mono-species Streptococcus biofilms. 
The antimicrobial effect is dose-dependent, with both the aqueous Auphen and Auphen-loaded gel 
demonstrating sustained efficacies at similar concentrations. Auphen in a gel carrier has the potential 
to be used as an antimicrobial medicament for the treatment of root canal infections. Further research 
is required to determine the exact mode of action, any toxic effects, effects on enamel/dentine and 
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Appendix D – Minimum inhibitory concentration 
Aqueous-Auphen 
Table D1 Bacterial growth after exposure to varying concentrations of aqueous-Auphen for 24 hours. The OD values plotted are mean ± SD. 
A Aqueous Auphen (mM) 
  
Mean ± SD 0 0.001 0.005 0.01 0.05 0.1 0.5 1 
S. mutans 0.415 ± 0.092 0.324 ± 0.079 0.285 ± 0.069 0.229 ± 0.036 0.186 ± 0.047 0.057 ± 0.039 0.033 ± 0.046 0.034 ± 0.036 
S. gordonii 0.478 ± 0.062 0.395 ± 0.079 0.315 ± 0.105 0.262 ± 0.076 0.201 ± 0.118 0.032 ± 0.005 0.027 ± 0.064 0.046 ± 0.049 
1234456 = lowest concentration whereby no visible growth evident after 24 hours incubation  
Auphen-loaded gel  
Table D2 Bacterial growth after exposure to varying concentrations of Auphen-loaded gels for 24 hours. The OD values plotted are mean ± SD. 
25% P407 + Auphen (mM) 
  
Mean ± SD 0 0.001 0.005 0.01 0.05 0.1 0.5 1 
S. mutans 0.394 ± 0.128 0.379 ± 0.119 0.274 ± 0.074 0.254 ± 0.058 0.179 ± 0.079  0.026 ± 0.012 0.041 ± 0.074 0.056 ± 0.121 
S. gordonii 0.423 ± 0.124 0.380 ± 0.112 0.335 ± 0.007 0.258 ± 0.043 0.152 ± 0.045 0.032 ± 0.008 0.016 ± 0.065 0.056 ± 0.032  
1234456 = lowest concentration of Auphen in P407 whereby no visible growth evident after 24 hours incubation
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Appendix E – Minimum inhibitory concentration S. gordonii DL1 
 
Aqueous-Auphen 
Table E1 Absorbance values attained at 600nm for S. gordonii DL1 after exposure to aqueous 
Auphen. The OD values plotted are mean ± standard deviation. 
Concentration (mM) Time 24 h 
(mean ± SD) 
p value 
0  0.478 ± 0.062 < 0.001 
0.001 0.395 ± 0.079 < 0.001 
0.005 0.315 ± 0.105 < 0.001 
0.01 0.262 ± 0.076  < 0.001 
0.05 0.201 ± 0.118 < 0.001 
0.1 0.032 ± 0.005 < 0.001 
0.5 0.027 ± 0.064 < 0.001 
1 0.046 ± 0.049 < 0.001 
 
Auphen-loaded gel  
Table E2 Absorbance values attained at 600nm for S. gordonii DL1 after exposure to Auphen-loaded 
P407 gels. The OD values plotted are mean ± standard deviation. 
Concentration (mM) Time 24 h 
(mean ± SD) 
p value 
0  0.423 ± 0.124 < 0.001 
0.001 0.380 ± 0.112 < 0.001 
0.005 0.335 ± 0.007 < 0.001 
0.01 0.258  ± 0.043 < 0.001 
0.05 0.152 ± 0.045 < 0.001 
0.1 0.032 ± 0.008 < 0.001 
0.5 0.016 ± 0.065 < 0.001 






Appendix F – Minimum inhibitory concentration S. mutans UAB159 
 
Aqueous-Auphen 
Table F1 Absorbance values attained at 600nm for S. mutans UAB159 after exposure to aqueous 
Auphen. The OD values plotted are mean ± standard deviation. 
 
 
Auphen-loaded gel  
Table F2 Absorbance values attained at 600nm for S. mutans UAB159 after exposure to Auphen-
loaded P407 gels. The OD values plotted are mean ± standard deviation. 
Concentration (mM) Time 24 h 
(mean ± SD) 
p value 
0  0.394 ± 0.128 < 0.001 
0.001 0.379 ± 0.229 < 0.001 
0.005 0.274 ± 0.074 < 0.001 
0.01 0.254 ±  0.054 < 0.001 
0.05 0.179 ±  0.079 < 0.001 
0.1 0.026 ± 0.026 < 0.001 
0.5 0.041 ± 0.074 < 0.001 
1 0.056 ± 0.121 < 0.001 
Concentration (mM) Time 24 h 
(mean ± SD) 
p value 
0  0.415 ±  0.092 < 0.001 
0.001 0.324 ± 0.079 < 0.001 
0.005 0.285 ± 0.069 < 0.001 
0.01 0.229 ± 0.036 < 0.001 
0.05 0.186 ± 0.047 < 0.001 
0.1 0.057 ± 0.039 < 0.001 
0.5 0.033 ± 0.046 < 0.001 
1 0.034 ± 0.036 < 0.001 
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